Next Article in Journal
Cooling Effect of Trees with Different Attributes and Layouts on the Surface Heat Island of Urban Street Canyons in Summer
Previous Article in Journal
Compositional Difference and Health Risk Assessment of Polycyclic Aromatic Hydrocarbons over the Coal Spontaneous Combustion Zone
Previous Article in Special Issue
Health Risks Forecast of Regional Air Pollution on Allergic Rhinitis: High-Resolution City-Scale Simulations in Changchun, China
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Cardiovascular and Respiratory Health Effects of Fine Particulate Matters (PM2.5): A Review on Time Series Studies

by
Wan Rozita Wan Mahiyuddin
1,
Rohaida Ismail
1,*,
Noraishah Mohammad Sham
1,
Nurul Izzah Ahmad
2 and
Nik Muhammad Nizam Nik Hassan
1
1
Climate Change Unit, Institute for Medical Research, National Institutes of Health, Ministry of Health Malaysia, Shah Alam 40170, Malaysia
2
Health Risk Assessment Unit, Institute for Medical Research, National Institutes of Health, Ministry of Health Malaysia, Shah Alam 40170, Malaysia
*
Author to whom correspondence should be addressed.
Atmosphere 2023, 14(5), 856; https://doi.org/10.3390/atmos14050856
Submission received: 8 February 2023 / Revised: 28 April 2023 / Accepted: 6 May 2023 / Published: 11 May 2023
(This article belongs to the Special Issue Air Pollution and Respiratory Health)

Abstract

:
Ambient air pollution remains one of the most important risk factors for health outcomes. In recent years, there has been a growing number of research linking particulate matter (PM) exposure with adverse health effects, especially on cardiovascular and respiratory systems. The objective of this review is to examine the range and nature of studies on time series analysis of health outcomes affected by PM2.5 across a broad research area. A literature search was conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) extension for scoping review framework through a strategic search of PubMed and ScienceDirect online databases for articles from January 2016 to January 2021. Articles were first screened by their titles and abstracts. Then two reviewers independently reviewed and evaluated the full text of the remaining articles for eligibility. Of the 407 potentially relevant studies, 138 articles were included for final analysis. There was an increasing trend in publications from 2016 to 2019 but a decreasing trend in the year 2020. Most studies were conducted in Eastern and South-Eastern Asia (69.6%), Europe and Northern America (14.5%) and Latin America and the Caribbean (8.7%), with the majority coming from high- and upper-middle-income countries (95.6%). The main methodology used was Generalized Additive Model (GAM) with Poisson distribution (74.6%). Morbidity was the most common health outcome studied (60.1%), with vulnerable groups (64.5%) often included. The association between PM2.5 and health effects was stronger for respiratory diseases compared to cardiovascular diseases. In short-term studies (less than 7 years), respiratory diseases showed higher risks compared to cardiovascular. However, in long-term studies (7 years and more), cardiovascular showed higher risks.

1. Introduction

Air pollution, including gaseous pollutants, volatile organics and particulate matter (PM), is a leading environmental issue for our planet, ecosystems, and future. Human anthropogenic activities contribute to the release of gaseous pollutants and particles into the atmosphere, for example, in smog episodes which are generally caused by high concentrations of PM with an aerodynamic diameter of 2.5 μm or less (PM2.5) [1]. Rapid development and urbanization globally are interconnected with air pollutants and climate change that have contributed to the global distribution of impacts and risks to both environment and human health [2]. Future trends of PM2.5 and ozone pollutants emission across countries in Southeast Asia are predicted to be rising following the interaction of anthropogenic emissions with certain climate and meteorological conditions [3].
The pathogenicity of PM to cardiorespiratory systems is determined by their physical properties, such as size, composition, and solubility [4,5,6]. This is also influenced by the origins of PM, either natural and/or man-made, that differentiate the chemical properties such as water-soluble ions and inorganic and organic compounds [6,7]. Furthermore, their ability to produce reactive oxygen would trigger inflammation in cardiorespiratory and other targeted organs [8,9,10]. PM with an aerodynamic diameter smaller than 10 µm (PM10) can be inhaled through the lungs and have impacts on human health. However, fine PM2.5, with relatively smaller diameters than PM10, can pass through the upper respiratory filtration, allowing the particles to reach the lower respiratory tract. PM2.5 also has a larger surface area per concentration to carry toxic substances. It will then accumulate and diffuse in the alveolar and could be distributed to other parts of the body through air exchange and cause systemic damage [11].
Many epidemiological studies in various geographical areas of the world, including multi-city studies, have shown significant associations between air pollution and adverse effects on human health, particularly affecting cardiovascular and respiratory systems [12,13,14]. Human exposure to PM air pollutants induces alveolar inflammation, contributes to metabolic diseases, and increases the risk of cardiovascular diseases [15,16]. Furthermore, exposure to air pollutants will worsen the conditions for those with pre-existing chronic cardiovascular and respiratory diseases and make them more susceptible to respiratory infection [17,18]. Both short- and long-term human exposure to PM2.5 raised the risk of cardiovascular and respiratory disease and mortality [19,20], and these associations were evidently shown in the earlier study of Harvard Six Cities that PM2.5 is one of the causative factors of non-accidental deaths [21].
Following trends for global emission and air pollution distribution, studies of air pollution and health effects have been advanced from simple descriptive studies to epidemiological approaches and then to regression models. Epidemiological approaches contribute to a better understanding of pollutants and disease distribution and identifying the causal relationship. Regression analysis, on the other hand, allows interpolating, modeling, and predicting the effects of air pollution on health. A time series design is the commonly used regression model in assessing ambient air pollutant exposure and health effects over time, and this approach is more precise in risk estimation compared to other regression analyses [22,23].
Scoping reviews have already been used to observe a variability of health-related issues and are useful for looking into a broad and different scope of evidence. Globally, there have been varied changes in ambient pollution in the past two decades, with most cities showing rising levels of PM2.5, especially in populous regions such as the Middle East, sub-Saharan Africa, and South Asia [24]. Existing reviews have systematically reviewed the literature from earlier years on the association between air pollution and health outcomes in broader topics [25,26,27,28]. However, reviews on time series analysis and specific health outcomes of cardiovascular and respiratory following exposure to PM2.5 were less explored. To fill the gaps in the literature, we conducted a comprehensive scoping review of the literature with a focus on the particular topic of PM2.5 air pollution and health effects related to cardiovascular and respiratory disease. The purposes of this review were as follows: (1) to examine the range and nature of studies on time series analysis design on health outcomes affected by PM2.5 across the broad research area, (2) to summarize the publication characteristics, and (3) to identify the gaps and potential future research.

2. Materials and Methods

This review is part of an ongoing study on the cardiovascular and respiratory health impacts of PM2.5 by the Institute for Medical Research, Ministry of Health Malaysia (NMRR-18-233-39743). It is being conducted to determine the distribution of published scientific articles on time series regression of PM2.5 and health effects by geographic regions, with a focus on cardiovascular and respiratory disorders leading to hospital visits, admissions, and death. Our methodology framework was based on the 6 main steps of the scoping review, which include the process of linking the objectives and identified research questions, identifying and selecting relevant studies, charting data, collating and reporting results, and consulting with experts [29,30].

2.1. Stage 1: Identifying the Research Question

Although many studies had been conducted on air pollution, most were focused on PM10 and gaseous pollutants. Therefore, as mentioned above, this scoping review will concentrate on PM2.5.

2.2. Stage 2: Identifying Relevant Studies

This review included primary research articles published in peer-reviewed journals. Only studies with relevant English-language articles conducted using time series design were included. This was to ensure that only articles with similar study designs were selected and compared. The following observational study designs were excluded: case-control, cohort, cross-sectional, panel (including randomized, crossover design), experimental, and case-crossover studies. Review papers such as systematic reviews, meta-analyses, scoping reviews, and critical reviews were also excluded, as well as conference proceedings and narrative reviews.

2.3. Stage 3: Study Selection

This study was conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) extension for scoping review framework [29,30]. A search strategy was run on the 2 main available databases at the National Institute of Health (NIH) Malaysia, which were PubMed and Science Direct. The articles included primary epidemiological studies that utilized time series design. There were 3 important steps in identifying all relevant articles:
  • Search strategy for identifying only articles published in English. Keywords used Boolean operators (OR, AND) during the search process;
    • cardiovascular OR CVD, respiratory, cardiorespiratory, AND;
    • PM2.5 OR particulate matter 2.5, AND;
    • time series.
2.
All articles were restricted to those that have been published from January 2016 to January 2021 to limit the search to recent publications within the previous 5 years;
3.
To avoid duplications and biases, the researchers reviewed together each of the articles to screen titles and abstracts from the databases for eligibility. In the next step, two reviewers independently reviewed and evaluated the full-text articles. Only primary research articles were evaluated to confirm inclusion based on the methodology used on the exposure and association assessment criteria.

2.4. Stage 4: Charting the Data

Data extracted from selected articles were entered into a database using MS Excel Spreadsheet and SPSS software ver. 22, so that the following relevant data could be recorded and charted as well as presented according to the variables of interest.

2.5. Stage 5: Collating, Reporting, and Summarizing the Results

Key information on the study characteristics that were charted during the review processes is listed below:
  • Authors names;
  • Year of publication;
  • Duration and year of study;
  • Study location by country and continent;
  • Cardiovascular and respiratory diseases;
  • International Statistical Classification of Diseases and Related Health Problems (ICD);
  • Health endpoints (either mortality, hospital admissions, hospital visits, or emergency visits);
  • Types of susceptible groups (either children, adults, the elderly, or not specified);
  • The most frequent design used in time series analysis are the Generalized Additive Model (GAM), Generalized Linear Model (GLM), and Negative Binomial (NB);
  • The descriptive of RRs associated with each disease.
Finally, the scoping review results were tabulated in order to find research gaps to either enable meaningful future research or obtain good pointers for policymaking.

2.6. Stage 6: Consultation with Experts

The authors of this study were priorly trained in scoping reviews by experts from Institute for Public Health Malaysia. The training provided guidance on scoping, systematic, and narrative review studies. The authors are also experts in the field of public health, environmental epidemiology and biostatistics.

3. Results

The first step in this review was searching for articles published in online databases, focusing on the effects of PM2.5 on health. The search started in February 2021, using four different keyword combinations, of which a total of 407 potentially relevant articles were identified from the PubMed and Science Direct databases. A total of 140 articles were found to be duplicated and were then removed, leaving only 267 remaining articles. A total of 102 articles were omitted after screening through the titles and abstracts as they were not pertinent to the objective of the study, and 27 more articles were excluded after a full-text review for various reasons, bringing the total number of articles included in this scoping at 138 (Figure 1 and Table S1).
A total of 138 articles were included in this review on PM2.5-related health effects for the 5-years period from January 2016 to January 2021 (Figure 2). The year 2019 had the largest count of articles published (n = 41), while the year 2016 had the lowest (n = 14), excluding the year 2021, which only contained the month of January. The selected time series studies of PM2.5 on cardiovascular and respiratory health outcomes were published from almost all the geographic regions around the world. The majority of PM2.5 time series and health effects studies selected were conducted in the Eastern and South-Eastern Asia region (69.6%), followed by Europe and Northern America (14.5%), and Latin America and the Caribbean (8.7%). Nine articles were published from other regions: Central & Southern Asia (n = 4), Northern Africa & Western Asia (n = 3), and Oceania (n = 2). One multi-country study was conducted in multiple regions on six continents; however, most of the cities were mainly located in East Asia, Europe, and North America, with a smaller number of cities in Latin America and Africa [31].
The included income groups are based on the World Bank Gross National Income (GNI) Economies, with about three-quarters of the human population currently living in countries defined as lower- or upper-middle-income economies [32]. We found that most of the studies (71.0%) have been conducted in upper-middle-income economies, mainly in Brazil, China, Colombia, Thailand, and Turkiye [Figure 3a]. This was followed by 34 (24.6%) articles from the high-income economies involving eleven countries. There were fewer selected articles from the lower-middle-income economies (3.6%), with only two countries involved (Iran and Vietnam). There was no published article on a time series study of PM2.5 with cardiovascular and respiratory effects found for low-income economies.
Figure 3b provides the general characteristics of epidemiologic time series studies by country. China has the highest number (n = 83) of studies selected, which shows that epidemiologic studies of both acute and chronic effects of PM2.5 have been well conducted there. This was followed by the United States and Brazil, with 10 published articles selected from each country. Four articles each were selected from Poland, South Korea, and Iran. There was minimal publication from other countries, with only one published article being included: Finland, Germany, Turkiye, Singapore, and Vietnam. While the majority of time series studies echoed the concerns of only a particular country, an article reported on the association of PM pollution with cardiovascular and respiratory mortality from 652 cities in 24 countries [31].
Studies on time series of PM2.5 with cardiovascular and respiratory health effects were interdisciplinary research areas and published in various international journals. More than half of the articles (63.8%) were frequently published in these top 9 journals (Figure 4). The Environmental Science and Pollution Research (ESPR) cumulatively published the highest number of related articles in the 5 years from 2016 to 2021 (n = 21), followed by the International Journal of Environmental Research and Public Health (IJERPH; n = 15) and Science of the Total Environment (STOTEN; n = 14). Other frequently published journals were on the multi-disciplinary application between the environment and health, including the BMC Public Health, Ecotoxicology and Environmental Safety, Environmental Health Perspectives (EHP), Chemosphere, and Environmental Research. The rest of the articles were published less frequently in another 38 journals that focused on environmental sciences (i.e., pollution and toxicology, hygiene, and safety) and health (i.e., public health, medical and clinical).
Time series studies require a group of data observations over an interval of time, and longer exposure to PM2.5 of more than 12 months is expected to have cumulative cardiovascular and respiratory health effects. There were six time series studies conducted for a minimum period of 1 year, while there was only one study conducted for the maximum duration of 30 years (Table 1). However, we reviewed the relation of climate change detection based on meteorological time series data, and a study on visual analytics indicated that 7 years of duration would show notable and consistent warming tendencies [33]. Our review showed more than three-quarters of studies (80.4%) had analyzed PM2.5 effects on cardiovascular and respiratory health outcomes by collecting data for less than 7 years (Table 1).
A widely used approach for time-series analysis of air pollution and health involves a semi-parametric Poisson regression with daily mortality or morbidity counts as the outcome [34]. There are two main approaches commonly used to estimate the effects associated with exposure to air pollution while accounting for smooth fluctuations in mortality that confound estimates of the effects of air pollution. One is the semi-parametric Poisson regression comprised of a Generalized Linear Model (GLM) with parametric splines, for example, natural cubic splines [35]. The other is the Generalized Additive Model (GAM) with nonparametric splines such as smoothing splines or locally weighted smoothers [36]. The GAM with Poisson regression was the main statistical methodology (74.6%) used in the analysis of selected articles, followed by the GLM and Poisson (17.4%). The estimation procedure in both analyses requires iterative approximations to find the optimal estimates. The difference is that the GLM emphasizes estimation and inference for the parameters of the model, while the GAM focuses on exploring the relationship between the dependent variable and the independent variables through visualization techniques.
The other time series methodologies were less explored in establishing the relationship. Only two studies used the Negative Binomial analysis. At the same time, nine other studies used different time series methodologies, such as the Bayesian Hierarchical Model, Inverse Probability Weighting, and Generalized Estimating Equation (GEE). These methods were not popularly used in regression time series studies, especially in finding the risk estimates of air pollution.
The ICD description of the 10th Revision (ICD-10) and/or the 9th Revision (ICD-9) was used in the majority (n = 114) of the studies. The ICD-10 (71.0%) was mostly utilized to classify cardiovascular and respiratory diseases compared to the ICD-9 (8.0%). The ICD-10 and ICD-9 codes for overall cardiovascular diseases known as circulatory system diseases are I00–I99 and 390–459, respectively. Fifty-seven percent of studies on this topic were conducted using these codes. The remaining were conducted on various specific cardiovascular diseases such as ischemic heart disease (IHD; ICD-10: I20–I25; ICD-9: 410–414), cerebral vascular disease (ICD-10: I60–I69) and Acute Myocardial Infarction (AMI; I20–I22) and congestive heart failure (ICD-9: 429). As for overall respiratory diseases, J00–J99 and 460–519 are the ICD-10 and ICD-9 codes, respectively, of the disease. More studies were conducted on specific ICD-10 or ICD-9 codes such as pneumonia (ICD-10: J00–J18; ICD-9: 480–488), asthma (ICD-10: J45–J46; ICD-9: 493), chronic obstructive pulmonary disease (COPD; ICD-10: J40–J44; ICD-9: 491–492), acute upper respiratory infection (AURI) (J00–J06), acute lower respiratory infection (ALRI; J20–J22), and rhinitis (J31). Less than five percent of the studies utilized the combinations of both ICDs. The remaining 24 studies used general classification based on symptom (i.e., wheezing) or diagnosis (i.e., asthma, chest infection, myocardial infarction, congestive heart failure, ischemic stroke, etc.).
The majority of the studies (64.5%) looked at specific age groups, namely children and the elderly, who were the most vulnerable (Table 2). The children’s age group ranged from ages 0 to 18 years old. While most of the studies utilized 65 years old and above as the elderly group, others did not specify the cut-off point of age that they used. We found that single health outcomes of cardiovascular and respiratory in relation to PM2.5 were commonly used (71.7%) as compared to combined health outcomes (29.3%). The most commonly used health outcomes were clinic/or ED visits (30.4%), followed by mortality only (29.7%) and hospital admissions only (29.7%). While fewer studies investigated the combined health outcomes (10.1%), the combination of admissions and clinic/or ED visits were conducted frequently (10 studies) as compared to other combinations. Nearly half (44.8%) of studies conducted among the elderly (only) were investigating the mortality outcomes. All studies among children (only) looked into morbidity outcomes of clinic or ED visits (64.7%) and admission (35.3%).
From the 138 studies, nearly half (44.9%) focused solely on respiratory disease, and 39 (28.3%) were on the combination of both cardiovascular and respiratory diseases (Table 2). While the study on cardiovascular disease only made up the remaining (26.8%). All studies conducted among children (only) explored respiratory disease outcomes. At the same time, studies on cardiovascular, respiratory, and both disease outcomes were well distributed in the elderly (only) and all age groups.
Long-term time series studies of 7 years and more were frequently conducted in Europe & Northern America (44.4%) and Eastern & South-Eastern Asia (33.3%) compared to other regions (Table 3). The United States conducted most of the studies (n = 9), followed by China (n = 4), and two studies in each Australia and South Korea. Most of the long-term studies (40.7%) investigated both cardiovascular and respiratory diseases. However, studies on single health effects of cardiovascular disease (n = 10) were higher compared to respiratory disease (n = 6). More than half of long-term studies explored the vulnerable groups, with 11 studies observing the association between younger and older age groups and seven studies on gender. Only one study reported the findings on the association between poverty with PM2.5 and respiratory hospital admissions.
The summary statistics of relative risks (RRs) reported by types of diseases are mainly the average of mean, quartiles, minimum and maximum values from all the selected articles (Table 4). The reported statistics of RRs by diseases are useful in estimating the burden of the disease and are tabulated by the duration of the study (short-term and long-term durations). Studies with less than 7 years’ duration were classified as short-term, while studies lasting longer than or equal to 7 years were classified as long-term. In short-term studies, respiratory diseases showed higher RRs in mainly all the statistics compared to cardiovascular. However, in long-term studies, cardiovascular showed higher RRs. Smaller standard deviations in long-term duration for both diseases showed better precision estimates.

4. Discussion

Our review provided an overview of current literature using time series designs to look for the association between PM2.5 with specific health outcomes of cardiovascular and respiratory diseases. We adhered to the methodology outlined for scoping review articles by using the six main principles of Arksey and O’Malley (2005) [29]. The guiding principle ensured that our methods were transparent and free from potential bias. There were a few identified strengths of the included studies, which have similar study design and methodology and broad geographical coverage. We hope that it will aid us in identifying research gaps and distributing research findings to stakeholders, policymakers, practitioners, and academics for possibly valuable directions and future research.
The results of this study showed that China published the highest number of articles on PM2.5 air pollution and cardiorespiratory health effects using time series designs. China is one of the countries that faced the worst air pollution problems in the world, possibly as a result of increasing industrialization and urbanization over the last two decades [63,64]. Coal is fuelling an increasing number of vehicles and industries, which are the principal contributors to the country’s dangerously high levels of air pollution [65]. Although coal-related pollution has always been a source of concern in China, coal burning during the winter months causes levels of airborne contaminants to increase drastically. According to one study, 40% of the PM2.5 in China’s atmosphere can be attributed to both industrial and residential sources of coal burning [66]. China had exceptionally severe and persistent haze pollution in the first quarter of 2013, affecting an area of more than 1.3 million km2 and nearly 800 million people [67]. The annual average PM2.5 and PM10 concentrations were 141 μg/m3 and 303 μg/m3, respectively [68]. Nearly half a million deaths in the country were related to PM2.5 exposure from a combination of coal burning at power plants, factories, and homes burning coal for heat and fuel.
PM2.5 levels are strongly related to meteorological variables such as temperature, relative humidity, and wind conditions, and the meteorological variations over the last 30 years related to the increment of the PM2.5 levels [69]. Data records of at least 30 years are considered appropriate to fully capture the variability of air pollution or other meteorological parameters that are associated with climate change [33]. However, daily data of 7 years and above was also enough to show notable and consistent changes. The majority of the studies (79.3%) in this review were conducted in a short period of time, which was less than seven years duration with daily data. As a result, the risks associated with health impacts have been considered to be short-term effects. There were many reasons why short-term studies were mainly conducted compared to long-duration studies. One of the main reasons was the ability to capture good data for daily environmental and health data. Many developing countries in various regions have taken action to address air pollution over the past decade. This action was prompted by the development of monitoring systems to document air pollution concentrations, particularly PM2.5 and with growing public awareness of high levels of pollutants in everyday life.
Our findings demonstrated that for long-term studies durations, the RRs were higher related to cardiovascular compared to respiratory diseases. This finding is consistent with results from other studies [70]. Many large prospective cohort studies and fine meta-analyses have further provided us with clear answers on the correlation between longer-term particulates exposure, particularly PM2.5 and cardiovascular mortality [71]. Furthermore, the majority of the studies on cardiovascular were conducted among the elderly, while most of the studies on respiratory diseases were conducted among children. Therefore, short-term durations were more appropriate for respiratory diseases.
The results from this study showed that about three-quarters of the studies utilized the GAM in data analysis, and the GLM was used in a few studies. The GAM with nonparametric splines and GLM with parametric splines are the statistical methods commonly employed for time-series analysis [35,36]. These regression methods account for variations in time-varying confounders like the season, weather factors, and other trends while estimating the relationship between short-term changes in air pollution and short-term changes in mortality. These results were consistent with what was reported by Bell et al. (2004), that of more than 80 time-series studies on PM and mortality published since 1996, approximately 70% used GAM methods [72]. This might be due to the fact that the GAM technique makes fewer rigid assumptions about temporal confounders and mortality effects and fulfill the default convergence criteria. Furthermore, the findings provided compelling evidence that short-term changes in even low levels of air pollution could be associated with short-term changes in mortality at a single location.
It should also be mentioned that PM2.5 concentration is currently only being monitored in certain countries compared to the monitoring of PM10 concentration which has been established in many countries. Even though the importance of PM2.5 in the determination of health effects has been established, it takes a certain level of investment to set up PM2.5 monitors or sensors. The World Health Organization (WHO) reported that coverage of the ground measurements of PM2.5 and PM10, respectively, are still not uniformly distributed around the world [73]. These monitoring stations were mainly located in high- and middle-income economies such as Europe and North America, India, and China. PM2.5 measurements can directly be used to estimate health impact and are therefore of particular interest. Thus, some middle-income countries have recently started to measure PM2.5; for example, Malaysia introduced new standards and guidelines for PM2.5 monitoring in 2017 [74]. This has improved its air quality monitoring network by incorporating continuous PM2.5 measurement into the national environmental monitoring program [75]. In comparison to PM10, monitoring PM2.5 allows for a better representation of the actual situation regarding high particulate matter concentrations owing to combustion, such as biomass burning and automobile emissions. When PM2.5 measurements are not available, PM10 measurements are used to estimate PM2.5. Due to that, there were studies that extrapolate PM2.5 data using PM10 data that is available from monitoring stations or from Aerosol Optical Depth (AOD) data using a method that has been developed and validated [76].
Surprisingly, 95% of the selected studies on the relationship between air pollution and health outcomes originated from either high-income countries (24.3%) or upper-middle-income countries (70.7%). There was less research from lower-middle-income countries (4.3%) and none from low-income countries. Even though this review was looking for specific designs and methodologies, this clear discrepancy could possibly be due to inadequate environmental monitoring systems and public health surveillance programs. Less cohesive policies and inadequate scientific research may be another reason. This presents an issue in understanding the impact on low-income countries. It is reported that stroke incidence is largely associated with low and middle-income countries rather than with high-income countries [77]. One approach to overcome this is to conduct a stratified analysis by regional income to try and explore the economic factor.
The ICD is internationally recognized for the diagnostic classification of both morbidity and mortality. The ICD-10 was introduced as the 2010 version to replace the earlier version of ICD-9 that was adopted internationally in the early 1980s [78]. The ICD-10 was adopted later by more than 100 countries. However, it differed by modifications made according to the country’s standard and specific clinical coding [79]. In this review, more than three-quarters of both cardiovascular and respiratory health outcomes used ICD codes. Even though health outcomes were classified using the same ICD codes, the different ways codes were used in mortality, admission, and ED visits were suggested to affect the comparability of specific categories of diseases, including cardiovascular and respiratory health effects [28,80]. With the latest version of ICD-11, which allows the systematic surveillance of mortality and morbidity data, both ICD-10 and ICD-11 classification adoption should be considered to ensure consistency of health outcomes [26].
The understanding of individual and population vulnerability to PM2.5 exposure will support the policy in reducing pollution. Our review attempted to look into the health effects of PM2.5 on cardiovascular and respiratory systems across different vulnerabilities such as gender, age groups, poorer and comorbidities. However, only age group was considered in more than half of the reviewed articles (60.8%). High levels of PM2.5 exposure negatively affected the cardiovascular and respiratory systems of children and the elderly, with specific ages below 15 years old and more than 65 years old, respectively [81,82]. The other reviewed articles did not focus on any particular vulnerable group.
More time series studies designed to look into the effects of air pollution on these vulnerable groups should be conducted. The effects on healthy people and those with chronic diseases need to be studied separately, as people with co-morbidities and chronic illnesses were more susceptible to air pollution. Prospective cohort studies have shown the association of long-term exposure to air pollution with chronic illnesses-related mortality [83]. Other subgroups that need to be analyzed separately includes people with outdoor occupations, athletes, infants and children, older adults and those with poor socioeconomic background.

5. Conclusions

There were numerous time series studies of PM2.5 on cardiovascular and respiratory health outcomes internationally in the last five years (2016–2021), mainly from the Eastern and South-Eastern Asia region. There was an unequal distribution of the epidemiologic studies of both acute and chronic effects of PM2.5 as they were well conducted in both upper-middle- and high-income economies. The GAM with Poisson regression analysis was the main methodology used in the analysis. The single health outcomes of cardiovascular or respiratory disease were often employed, with mortality being the most prevalent health outcome. Most studies focused solely on respiratory diseases, with many of them looking at the vulnerable groups and utilizing ICD-10 in both diseases. The findings also showed that short-term studies showed higher risks for respiratory diseases, while long-term studies showed higher risks for cardiovascular diseases. To provide more insights on the global burden of diseases related to PM2.5 pollution, more studies are needed to explore the impacts in lower incomes countries and other vulnerable populations.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/atmos14050856/s1, Table S1: List of 138 accepted articles for scoping review on time series studies of PM2.5 and health effects. References [84,85,86,87,88,89,90,91,92,93,94,95,96,97,98,99,100,101,102,103,104,105,106,107,108,109,110,111,112,113,114,115,116,117,118,119,120,121,122,123,124,125,126,127,128,129,130,131,132,133,134,135,136,137,138,139,140,141,142,143,144,145,146,147,148,149,150,151,152,153,154,155,156,157,158,159,160,161,162,163,164,165,166,167,168,169,170,171,172,173,174,175,176,177,178,179,180,181,182,183,184,185,186,187,188,189,190,191] have been cited in the Supplementary Materials.

Author Contributions

Conceptualization, W.R.W.M., R.I., N.M.S., N.M.N.N.H. and N.I.A.; methodology, W.R.W.M. and N.M.S.; software, W.R.W.M.; formal analysis, W.R.W.M., R.I., N.M.S., N.M.N.N.H. and N.I.A.; investigation, W.R.W.M., R.I., N.M.S., N.M.N.N.H. and N.I.A.; resources, W.R.W.M.; data curation, W.R.W.M. and R.I.; writing—original draft preparation, W.R.W.M., R.I., N.M.S. and N.M.N.N.H.; writing—review and editing, W.R.W.M., R.I., N.M.S., N.M.N.N.H. and N.I.A.; visualization, W.R.W.M. and R.I.; project administration, W.R.W.M. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by the Ministry of Health Malaysia under research code NMRR-18-233-39743.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Not applicable.

Acknowledgments

We would like to thank the Director General of Health Malaysia for his permission to publish this paper.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Zhang, X.; Sun, J.; Wang, Y.; Li, W.; Zhang, Q.; Wang, W.; Quan, J.; Cao, G.; Wang, J.; Yang, Y.; et al. Factors Contributing to Haze and Fog in China. Chin. Sci. Bull. 2013, 58, 1178–1187. [Google Scholar] [CrossRef]
  2. Marcantonio, R.; Javeline, D.; Field, S.; Fuentes, A. Global Distribution and Coincidence of Pollution, Climate Impacts, and Health Risk in the Anthropocene. PLoS ONE 2021, 16, e0254060. [Google Scholar] [CrossRef] [PubMed]
  3. Nguyen, G.T.H.; Shimadera, H.; Uranishi, K.; Matsuo, T.; Kondo, A. Numerical Assessment of PM2.5 and O3 Air Quality in Continental Southeast Asia: Impacts of Future Projected Anthropogenic Emission Change and Its Impacts in Combination with Potential Future Climate Change Impacts. Atmos. Environ. 2020, 226, 117398. [Google Scholar] [CrossRef]
  4. Snow, S.J.; De Vizcaya-Ruiz, A.; Osornio-Vargas, A.; Thomas, R.F.; Schladweiler, M.C.; McGee, J.; Kodavanti, U.P. The Effect of Composition, Size, and Solubility on Acute Pulmonary Injury in Rats Following Exposure to Mexico City Ambient Particulate Matter Samples. J. Toxicol. Environ. Health A 2014, 77, 1164–1182. [Google Scholar] [CrossRef]
  5. Araujo, J.A.; Nel, A.E. Particulate Matter and Atherosclerosis: Role of Particle Size, Composition and Oxidative Stress. Part. Fibre Toxicol. 2009, 6, 24. [Google Scholar] [CrossRef]
  6. Veremchuk, L.V.; Vitkina, T.I.; Barskova, L.S.; Gvozdenko, T.A.; Mineeva, E.E. Estimation of the Size Distribution of Suspended Particulate Matters in the Urban Atmospheric Surface Layer and Its Influence on Bronchopulmonary Pathology. Atmosphere 2021, 12, 1010. [Google Scholar] [CrossRef]
  7. Cachon, F.B.; Cazier, F.; Verdin, A.; Dewaele, D.; Genevray, P.; Delbende, A.; Ayi-Fanou, L.; Aïssi, F.; Sanni, A.; Courcot, D. Physicochemical Characterization of Air Pollution Particulate Matter (PM2.5 and PM > 2.5) in an Urban Area of Cotonou, Benin. Atmosphere 2023, 14, 201. [Google Scholar] [CrossRef]
  8. Rao, X.; Zhong, J.; Brook, R.D.; Rajagopalan, S. Effect of Particulate Matter Air Pollution on Cardiovascular Oxidative Stress Pathways. Antioxid. Redox Signal. 2018, 28, 797–818. [Google Scholar] [CrossRef]
  9. Mazzoli-Rocha, F.; Fernandes, S.; Einicker-Lamas, M.; Zin, W.A. Roles of Oxidative Stress in Signaling and Inflammation Induced by Particulate Matter. Cell. Biol. Toxicol. 2010, 26, 481–498. [Google Scholar] [CrossRef]
  10. Pizzino, G.; Irrera, N.; Cucinotta, M.; Pallio, G.; Mannino, F.; Arcoraci, V.; Squadrito, F.; Altavilla, D.; Bitto, A. Oxidative Stress: Harms and Benefits for Human Health. Oxid. Med. Cell. Longev. 2017, 2017, 8416763. [Google Scholar] [CrossRef]
  11. Xing, Y.-F.; Xu, Y.-H.; Shi, M.-H.; Lian, Y.-X. The Impact of PM2.5 on the Human Respiratory System. J. Thorac. Dis. 2016, 8, E69–E74. [Google Scholar]
  12. Dastoorpoor, M.; Khanjani, N.; Moradgholi, A.; Sarizadeh, R.; Cheraghi, M.; Estebsari, F. Prenatal Exposure to Ambient Air Pollution and Adverse Pregnancy Outcomes in Ahvaz, Iran: A Generalized Additive Model. Int. Arch. Occup. Environ. Health 2021, 94, 309–324. [Google Scholar] [CrossRef]
  13. Phosri, A.; Ueda, K.; Phung, V.L.H.; Tawatsupa, B.; Honda, A.; Takano, H. Effects of Ambient Air Pollution on Daily Hospital Admissions for Respiratory and Cardiovascular Diseases in Bangkok, Thailand. Sci. Total. Environ. 2019, 651, 1144–1153. [Google Scholar] [CrossRef]
  14. Slama, A.; Śliwczyński, A.; Woźnica, J.; Zdrolik, M.; Wiśnicki, B.; Kubajek, J.; Turżańska-Wieczorek, O.; Gozdowski, D.; Wierzba, W.; Franek, E. Impact of Air Pollution on Hospital Admissions with a Focus on Respiratory Diseases: A Time-Series Multi-City Analysis. Environ. Sci. Pollut. Res. 2019, 26, 16998–17009. [Google Scholar] [CrossRef]
  15. Brook, R.D.; Franklin, B.; Cascio, W.; Hong, Y.; Howard, G.; Lipsett, M.; Luepker, R.; Mittleman, M.; Samet, J.; Smith, S.C.; et al. Air Pollution and Cardiovascular Disease: A Statement for Healthcare Professionals From the Expert Panel on Population and Prevention Science of the American Heart Association. Circulation 2004, 109, 2655–2671. [Google Scholar] [CrossRef]
  16. Hamanaka, R.B.; Mutlu, G.M. Particulate Matter Air Pollution: Effects on the Cardiovascular System. Front. Endocrinol. 2018, 9, 680. [Google Scholar] [CrossRef]
  17. Jiang, X.-Q.; Mei, X.-D.; Feng, D. Air Pollution and Chronic Airway Diseases: What Should People Know and Do? J. Thorac. Dis. 2016, 8, E31–E40. [Google Scholar]
  18. Lee, B.-J.; Kim, B.; Lee, K. Air Pollution Exposure and Cardiovascular Disease. Toxicol. Res. 2014, 30, 71–75. [Google Scholar] [CrossRef]
  19. Kloog, I.; Ridgway, B.; Koutrakis, P.; Coull, B.A.; Schwartz, J.D. Long- and Short-Term Exposure to PM2.5 and Mortality. Epidemiology 2013, 24, 555–561. [Google Scholar] [CrossRef]
  20. Zhang, Y.; Liu, L.; Zhang, L.; Yu, C.; Wang, X.; Shi, Z.; Hu, J.; Zhang, Y. Assessing Short-Term Impacts of PM2.5 Constituents on Cardiorespiratory Hospitalizations: Multi-City Evidence from China. Int. J. Hyg. Environ. Health 2022, 240, 113912. [Google Scholar] [CrossRef]
  21. Dockery, D.W.; Pope, C.A.; Xu, X.; Spengler, J.D.; Ware, J.H.; Fay, M.E.; Ferris, B.G.; Speizer, F.E. An Association between Air Pollution and Mortality in Six U.S. Cities. N. Engl. J. Med. 1993, 329, 1753–1759. [Google Scholar] [CrossRef] [PubMed]
  22. Fung, K.Y.; Krewski, D.; Chen, Y.; Burnett, R.; Cakmak, S. Comparison of Time Series and Case-Crossover Analyses of Air Pollution and Hospital Admission Data. Int. J. Epidemiol. 2003, 32, 1064–1070. [Google Scholar] [CrossRef] [PubMed]
  23. Slama, A.; Śliwczyński, A.; Woźnica-Pyzikiewicz, J.; Zdrolik, M.; Wiśnicki, B.; Kubajek, J.; Turżańska-Wieczorek, O.; Studnicki, M.; Wierzba, W.; Franek, E. The Short-Term Effects of Air Pollution on Respiratory Disease Hospitalizations in 5 Cities in Poland: Comparison of Time-Series and Case-Crossover Analyses. Environ. Sci. Pollut. Res. Int. 2020, 27, 24582–24590. [Google Scholar] [CrossRef] [PubMed]
  24. Sicard, P.; Agathokleous, E.; Anenberg, S.C.; De Marco, A.; Paoletti, E.; Calatayud, V. Trends in Urban Air Pollution over the Last Two Decades: A Global Perspective. Sci. Total Environ. 2023, 858, 160064. [Google Scholar] [CrossRef]
  25. Manisalidis, I.; Stavropoulou, E.; Stavropoulos, A.; Bezirtzoglou, E. Environmental and Health Impacts of Air Pollution: A Review. Front. Public Health 2020, 8, 14. [Google Scholar] [CrossRef]
  26. Sun, Z.; Zhu, D. Exposure to Outdoor Air Pollution and Its Human Health Outcomes: A Scoping Review. PLoS ONE 2019, 14, e0216550. [Google Scholar] [CrossRef]
  27. Anderson, J.O.; Thundiyil, J.G.; Stolbach, A. Clearing the Air: A Review of the Effects of Particulate Matter Air Pollution on Human Health. J. Med. Toxicol. 2012, 8, 166–175. [Google Scholar] [CrossRef]
  28. Atkinson, R.W.; Kang, S.; Anderson, H.R.; Mills, I.C.; Walton, H.A. Epidemiological Time Series Studies of PM2.5 and Daily Mortality and Hospital Admissions: A Systematic Review and Meta-Analysis. Thorax 2014, 69, 660–665. [Google Scholar] [CrossRef]
  29. Arksey, H.; O’Malley, L. Scoping Studies: Towards a Methodological Framework. Int. J. Soc. Res. Methodol. 2005, 8, 19–32. [Google Scholar] [CrossRef]
  30. Levac, D.; Colquhoun, H.; O’Brien, K.K. Scoping Studies: Advancing the Methodology. Implement. Sci. 2010, 5, 69. [Google Scholar] [CrossRef]
  31. Liu, C.; Chen, R.; Sera, F.; Vicedo-Cabrera, A.M.; Guo, Y.; Tong, S.; Coelho, M.S.Z.S.; Saldiva, P.H.N.; Lavigne, E.; Matus, P.; et al. Ambient Particulate Air Pollution and Daily Mortality in 652 Cities. N. Engl. J. Med. 2019, 381, 705–715. [Google Scholar] [CrossRef]
  32. World Bank How Does the World Bank Classify Countries?—World Bank Data Help Desk. Available online: https://datahelpdesk.worldbank.org/knowledgebase/articles/378834-how-does-the-world-bank-classify-countries (accessed on 16 February 2022).
  33. Vuckovic, M.; Schmidt, J. Visual Analytics for Climate Change Detection in Meteorological Time-Series. Forecasting 2021, 3, 276–289. [Google Scholar] [CrossRef]
  34. Pan, A.; Sarnat, S.E.; Chang, H.H. Time-Series Analysis of Air Pollution and Health Accounting for Covariate-Dependent Overdispersion. Am. J. Epidemiol. 2018, 187, 2698–2704. [Google Scholar] [CrossRef]
  35. McCullagh, P.; Nelder, J.A. Generalized Linear Models, 2nd ed.; Chapman and Hall/CRC: London, UK, 1989; ISBN 978-0-412-31760-6. [Google Scholar]
  36. Hastie, T.J.; Tibshirani, R.J. Generalized Additive Models; CRC Press: Boca Raton, FL, USA, 1990; ISBN 978-0-412-34390-2. [Google Scholar]
  37. Chai, G.; He, H.; Sha, Y.; Zhai, G.; Zong, S. Effect of PM2.5 on Daily Outpatient Visits for Respiratory Diseases in Lanzhou, China. Sci. Total Environ. 2019, 649, 1563–1572. [Google Scholar] [CrossRef]
  38. Chen, Q.; Wang, Q.; Xu, B.; Xu, Y.; Ding, Z.; Sun, H. Air Pollution and Cardiovascular Mortality in Nanjing, China: Evidence Highlighting the Roles of Cumulative Exposure and Mortality Displacement. Chemosphere 2021, 265, 129035. [Google Scholar] [CrossRef]
  39. Xu, J.; Geng, W.; Geng, X.; Cui, L.; Ding, T.; Xiao, C.; Zhang, J.; Tang, J.; Zhai, J. Study on the Association between Ambient Air Pollution and Daily Cardiovascular Death in Hefei, China. Environ. Sci. Pollut. Res. 2020, 27, 547–561. [Google Scholar] [CrossRef]
  40. Lin, H.; Ma, W.; Qiu, H.; Vaughn, M.G.; Nelson, E.J.; Qian, Z.; Tian, L. Is Standard Deviation of Daily PM2.5 Concentration Associated with Respiratory Mortality? Environ. Pollut. 2016, 216, 208–214. [Google Scholar] [CrossRef]
  41. Lin, H.; Ma, W.; Qiu, H.; Wang, X.; Trevathan, E.; Yao, Z.; Dong, G.-H.; Vaughn, M.G.; Qian, Z.; Tian, L. Using Daily Excessive Concentration Hours to Explore the Short-Term Mortality Effects of Ambient PM2.5 in Hong Kong. Environ. Pollut. 2017, 229, 896–901. [Google Scholar] [CrossRef]
  42. Yap, J.; Ng, Y.; Yeo, K.K.; Sahlén, A.; Lam, C.S.P.; Lee, V.; Ma, S. Particulate Air Pollution on Cardiovascular Mortality in the Tropics: Impact on the Elderly. Environ. Health 2019, 18, 34. [Google Scholar] [CrossRef]
  43. Kwon, O.K.; Kim, S.-H.; Kang, S.-H.; Cho, Y.; Oh, I.-Y.; Yoon, C.-H.; Kim, S.-Y.; Kim, O.-J.; Choi, E.-K.; Youn, T.-J.; et al. Association of Short- and Long-Term Exposure to Air Pollution with Atrial Fibrillation. Eur. J. Prev. Cardiol. 2019, 26, 1208–1216. [Google Scholar] [CrossRef]
  44. Oh, J.; Han, C.; Lee, D.-W.; Jang, Y.; Choi, Y.-J.; Bae, H.J.; Kim, S.; Ha, E.; Hong, Y.-C.; Lim, Y.-H. Short-Term Exposure to Fine Particulate Matter and Hospitalizations for Acute Lower Respiratory Infection in Korean Children: A Time-Series Study in Seven Metropolitan Cities. Int. J. Environ. Res. Public. Health 2020, 18, 144. [Google Scholar] [CrossRef] [PubMed]
  45. Qiu, H.; Bai, C.-H.; Chuang, K.-J.; Fan, Y.-C.; Chang, T.-P.; Yim, S.H.-L.; Ho, K.-F. Association of Ambient Non-Methane Hydrocarbons Exposure with Respiratory Hospitalizations: A Time Series Study in Taipei, Taiwan. Sci. Total Environ. 2020, 729, 139010. [Google Scholar] [CrossRef] [PubMed]
  46. Guo, Y.; Gao, C.X.; Dennekamp, M.; Dimitriadis, C.; Straney, L.; Ikin, J.; Abramson, M.J. The Association of Coal Mine Fire Smoke with Hospital Emergency Presentations and Admissions: Time Series Analysis of Hazelwood Health Study. Chemosphere 2020, 253, 126667. [Google Scholar] [CrossRef] [PubMed]
  47. Salimi, F.; Henderson, S.B.; Morgan, G.G.; Jalaludin, B.; Johnston, F.H. Ambient Particulate Matter, Landscape Fire Smoke, and Emergency Ambulance Dispatches in Sydney, Australia. Environ. Int. 2017, 99, 208–212. [Google Scholar] [CrossRef]
  48. Strosnider, H.M.; Chang, H.H.; Darrow, L.A.; Liu, Y.; Vaidyanathan, A.; Strickland, M.J. Age-Specific Associations of Ozone and Fine Particulate Matter with Respiratory Emergency Department Visits in the United States. Am. J. Respir. Crit. Care Med. 2019, 199, 882–890. [Google Scholar] [CrossRef]
  49. Krall, J.R.; Mulholland, J.A.; Russell, A.G.; Balachandran, S.; Winquist, A.; Tolbert, P.E.; Waller, L.A.; Sarnat, S.E. Associations between Source-Specific Fine Particulate Matter and Emergency Department Visits for Respiratory Disease in Four U.S. Cities. Environ. Health Perspect. 2017, 125, 97–103. [Google Scholar] [CrossRef]
  50. Ye, D.; Klein, M.; Mulholland, J.A.; Russell, A.G.; Weber, R.; Edgerton, E.S.; Chang, H.H.; Sarnat, J.A.; Tolbert, P.E.; Ebelt Sarnat, S. Estimating Acute Cardiovascular Effects of Ambient PM2.5 Metals. Environ. Health Perspect. 2018, 126, 027007. [Google Scholar] [CrossRef]
  51. Ebisu, K.; Malig, B.; Hasheminassab, S.; Sioutas, C. Age-Specific Seasonal Associations between Acute Exposure to PM2.5 Sources and Cardiorespiratory Hospital Admissions in California. Atmos. Environ. 2019, 218, 117029. [Google Scholar] [CrossRef]
  52. Blomberg, A.J.; Coull, B.A.; Jhun, I.; Vieira, C.L.Z.; Zanobetti, A.; Garshick, E.; Schwartz, J.; Koutrakis, P. Effect Modification of Ambient Particle Mortality by Radon: A Time Series Analysis in 108 U.S. Cities. J. Air Waste Manag. Assoc. 2019, 69, 266–276. [Google Scholar] [CrossRef]
  53. Hsu, W.-H.; Hwang, S.-A.; Kinney, P.L.; Lin, S. Seasonal and Temperature Modifications of the Association between Fine Particulate Air Pollution and Cardiovascular Hospitalization in New York State. Sci. Total Environ. 2017, 578, 626–632. [Google Scholar] [CrossRef]
  54. Bi, J.; D’Souza, R.R.; Rich, D.Q.; Hopke, P.K.; Russell, A.G.; Liu, Y.; Chang, H.H.; Ebelt, S. Temporal Changes in Short-Term Associations between Cardiorespiratory Emergency Department Visits and PM2.5 in Los Angeles, 2005 to 2016. Environ. Res. 2020, 190, 109967. [Google Scholar] [CrossRef]
  55. Qiu, X.; Wei, Y.; Wang, Y.; Di, Q.; Sofer, T.; Awad, Y.A.; Schwartz, J. Inverse Probability Weighted Distributed Lag Effects of Short-Term Exposure to PM2.5 and Ozone on CVD Hospitalizations in New England Medicare Participants—Exploring the Causal Effects. Environ. Res. 2020, 182, 109095. [Google Scholar] [CrossRef]
  56. Yitshak-Sade, M.; Bobb, J.F.; Schwartz, J.D.; Kloog, I.; Zanobetti, A. The Association between Short and Long-Term Exposure to PM2.5 and Temperature and Hospital Admissions in New England and the Synergistic Effect of the Short-Term Exposures. Sci. Total Environ. 2018, 639, 868–875. [Google Scholar] [CrossRef]
  57. Pearce, J.L.; Neelon, B.; Bozigar, M.; Hunt, K.J.; Commodore, A.; Vena, J. Associations between Multipollutant Day Types and Select Cardiorespiratory Outcomes in Columbia, South Carolina, 2002 to 2013. Environ. Epidemiol. 2018, 2, e030. [Google Scholar] [CrossRef]
  58. Solimini, A.; Renzi, M. Association between Air Pollution and Emergency Room Visits for Atrial Fibrillation. Int. J. Environ. Res. Public Health 2017, 14, 661. [Google Scholar] [CrossRef]
  59. Kuźma, Ł.; Struniawski, K.; Pogorzelski, S.; Bachórzewska-Gajewska, H.; Dobrzycki, S. Gender Differences in Association between Air Pollution and Daily Mortality in the Capital of the Green Lungs of Poland–Population-Based Study with 2,953,000 Person-Years of Follow-Up. J. Clin. Med. 2020, 9, 2351. [Google Scholar] [CrossRef]
  60. Kollanus, V.; Tiittanen, P.; Niemi, J.V.; Lanki, T. Effects of Long-Range Transported Air Pollution from Vegetation Fires on Daily Mortality and Hospital Admissions in the Helsinki Metropolitan Area, Finland. Environ. Res. 2016, 151, 351–358. [Google Scholar] [CrossRef]
  61. Borsi, S.H.; Khanjani, N.; Nejad, H.Y.; Riahi, A.; Sekhavatpour, Z.; Raji, H.; Dastoorpoor, M. Air Pollution and Hospital Admissions Due to Deep Vein Thrombosis (DVT) in Ahvaz, Iran. Heliyon 2020, 6, e04814. [Google Scholar] [CrossRef]
  62. Tapia, V.; Steenland, K.; Sarnat, S.E.; Vu, B.; Liu, Y.; Sánchez-Ccoyllo, O.; Vasquez, V.; Gonzales, G.F. Time-Series Analysis of Ambient PM2.5 and Cardiorespiratory Emergency Room Visits in Lima, Peru during 2010–2016. J. Expo. Sci. Environ. Epidemiol. 2020, 30, 680–688. [Google Scholar] [CrossRef]
  63. Zhang, J.; Mauzerall, D.L.; Zhu, T.; Liang, S.; Ezzati, M.; Remais, J. Environmental Health in China: Challenges to Achieving Clean Air and Safe Water. Lancet 2010, 375, 1110–1119. [Google Scholar] [CrossRef]
  64. Mou, Y.; Song, Y.; Xu, Q.; He, Q.; Hu, A. Influence of Urban-Growth Pattern on Air Quality in China: A Study of 338 Cities. Int. J. Environ. Res. Public. Health 2018, 15, 1805. [Google Scholar] [CrossRef] [PubMed]
  65. Wu, Y.; Wang, R.; Zhou, Y.; Lin, B.; Fu, L.; He, K.; Hao, J. On-Road Vehicle Emission Control in Beijing: Past, Present, and Future. Environ. Sci. Technol. 2011, 45, 147–153. [Google Scholar] [CrossRef] [PubMed]
  66. Health Effects Institute Burden of Disease Attributable to Coal-Burning and Other Air Pollution Sources in China. Available online: https://www.healtheffects.org/publication/burden-disease-attributable-coal-burning-and-other-air-pollution-sources-china (accessed on 14 February 2022).
  67. Huang, R.-J.; Zhang, Y.; Bozzetti, C.; Ho, K.-F.; Cao, J.-J.; Han, Y.; Daellenbach, K.R.; Slowik, J.G.; Platt, S.M.; Canonaco, F.; et al. High Secondary Aerosol Contribution to Particulate Pollution during Haze Events in China. Nature 2014, 514, 218–222. [Google Scholar] [CrossRef] [PubMed]
  68. Song, J.; Zheng, L.; Lu, M.; Gui, L.; Xu, D.; Wu, W.; Liu, Y. Acute Effects of Ambient Particulate Matter Pollution on Hospital Admissions for Mental and Behavioral Disorders: A Time-Series Study in Shijiazhuang, China. Sci. Total. Environ. 2018, 636, 205–211. [Google Scholar] [CrossRef]
  69. Requia, W.J.; Jhun, I.; Coull, B.A.; Koutrakis, P. Climate Impact on Ambient PM2.5 Elemental Concentration in the United States: A Trend Analysis over the Last 30 Years. Environ. Int. 2019, 131, 104888. [Google Scholar] [CrossRef]
  70. Hoek, G.; Krishnan, R.M.; Beelen, R.; Peters, A.; Ostro, B.; Brunekreef, B.; Kaufman, J.D. Long-Term Air Pollution Exposure and Cardio- Respiratory Mortality: A Review. Environ. Health 2013, 12, 43. [Google Scholar] [CrossRef]
  71. Beelen, R.; Stafoggia, M.; Raaschou-Nielsen, O.; Andersen, Z.J.; Xun, W.W.; Katsouyanni, K.; Dimakopoulou, K.; Brunekreef, B.; Weinmayr, G.; Hoffmann, B.; et al. Long-Term Exposure to Air Pollution and Cardiovascular Mortality: An Analysis of 22 European Cohorts. Epidemiology 2014, 25, 368–378. [Google Scholar] [CrossRef]
  72. Bell, M.L.; Samet, J.M.; Dominici, F. Time-Series Studies of Particulate Matter. Annu. Rev. Public. Health 2004, 25, 247–280. [Google Scholar] [CrossRef]
  73. WHO. Ambient (Outdoor) Air Quality Database: Summary Results, Update 2018; World Health Organization (WHO): Geneva, Switzerland, 2018. [Google Scholar]
  74. Department of Environment; Ministry of Natural Resources, Environment and Climate Change; Department of Environmen Air Quality Standards. Available online: https://www.doe.gov.my/en/2021/12/15/air-quality-standards/ (accessed on 3 March 2023).
  75. Rahman, E.A.; Hamzah, F.M.; Latif, M.T.; Dominick, D. Assessment of PM2.5 Patterns in Malaysia Using the Clustering Method. Aerosol Air Qual. Res. 2022, 22, 210161. [Google Scholar] [CrossRef]
  76. Rodrigues, P.C.; Pinheiro, S.; Junger, W.; Ignotti, E.; Hacon, S. Variabilidade Climática Aumenta a Morbimortalidade Associada Ao Material Particulado. Rev. Saúde Pública 2017, 51, 91. [Google Scholar] [CrossRef]
  77. Johnson, W.; Onuma, O.; Owolabi, M.; Sachdev, S. Stroke: A Global Response Is Needed. Bull. World Health Organ. 2016, 94, 634–634A. [Google Scholar] [CrossRef]
  78. Topaz, M.; Shafran-Topaz, L.; Bowles, K.H. ICD-9 to ICD-10: Evolution, Revolution, and Current Debates in the United States. Perspect. Health Inf. Manag. 2013, 10, 1d. [Google Scholar]
  79. Otero Varela, L.; Doktorchik, C.; Wiebe, N.; Quan, H.; Eastwood, C. Exploring the Differences in ICD and Hospital Morbidity Data Collection Features across Countries: An International Survey. BMC Health Serv. Res. 2021, 21, 308. [Google Scholar] [CrossRef]
  80. Ito, K.; Mathes, R.; Ross, Z.; Nádas, A.; Thurston, G.; Matte, T. Fine Particulate Matter Constituents Associated with Cardiovascular Hospitalizations and Mortality in New York City. Environ. Health Perspect. 2011, 119, 467–473. [Google Scholar] [CrossRef]
  81. Chu, H.; Xin, J.; Yuan, Q.; Zhang, X.; Pan, W.; Zeng, X.; Chen, Y.; Ma, G.; Ge, Y.; Du, M.; et al. Evaluation of Vulnerable PM2.5-Exposure Individuals: A Repeated-Measure Study in an Elderly Population. Environ. Sci. Pollut. Res. Int. 2018, 25, 11833–11840. [Google Scholar] [CrossRef]
  82. Li, S.; Cao, S.; Duan, X.; Zhang, Y.; Gong, J.; Xu, X.; Guo, Q.; Meng, X.; Bertrand, M.; Zhang, J.J. Long-Term Exposure to PM2.5 and Children’s Lung Function: A Dose-Based Association Analysis. J. Thorac. Dis. 2020, 12, 6379–6395. [Google Scholar] [CrossRef]
  83. Zhang, Z.; Wang, J.; Kwong, J.C.; Burnett, R.T.; van Donkelaar, A.; Hystad, P.; Martin, R.V.; Bai, L.; McLaughlin, J.; Chen, H. Long-Term Exposure to Air Pollution and Mortality in a Prospective Cohort: The Ontario Health Study. Environ. Int. 2021, 154, 106570. [Google Scholar] [CrossRef]
  84. Bravo, M.A.; Ebisu, K.; Dominici, F.; Wang, Y.; Peng, R.D.; Bell, M.L. Airborne Fine Particles and Risk of Hospital Admissions for Understudied Populations: Effects by Urbanicity and Short-Term Cumulative Exposures in 708 U.S. Counties. Environ. Health Perspect. 2017, 125, 594–601. [Google Scholar] [CrossRef]
  85. Çapraz, Ö.; Deniz, A.; Doğan, N. Effects of Air Pollution on Respiratory Hospital Admissions in İstanbul, Turkey, 2013 to 2015. Chemosphere 2017, 181, 544–550. [Google Scholar] [CrossRef]
  86. Chen, R.; Gao, Q.; Sun, J.; Yang, H.; Li, Y.; Kang, F.; Wu, W. Short-Term Effects of Particulate Matter Exposure on Emergency Room Visits for Cardiovascular Disease in Lanzhou, China: A Time Series Analysis. Environ. Sci. Pollut. Res. 2020, 27, 9327–9335. [Google Scholar] [CrossRef]
  87. Kowalska, M.; Skrzypek, M.; Kowalski, M.; Cyrys, J. Effect of NOx and NO2 Concentration Increase in Ambient Air to Daily Bronchitis and Asthma Exacerbation, Silesian Voivodeship in Poland. Int. J. Environ. Res. Public Health 2020, 17, 754. [Google Scholar] [CrossRef] [PubMed]
  88. Leepe, K.A.; Li, M.; Fang, X.; Hiyoshi, A.; Cao, Y. Acute Effect of Daily Fine Particulate Matter Pollution on Cerebrovascular Mortality in Shanghai, China: A Population-Based Time Series Study. Environ. Sci. Pollut. Res. Int. 2019, 26, 25491–25499. [Google Scholar] [CrossRef] [PubMed]
  89. Lu, M.; Yang, H.; Wang, J.; An, Z.; Li, J.; Wu, Z.; Zhao, Q.; Li, H.; Zhai, D.; Liu, Y.; et al. Acute Effects of Ambient Air Pollution on Outpatients with Chronic Rhinitis in Xinxiang, China. Environ. Sci. Pollut. Res. Int. 2021, 28, 9889–9897. [Google Scholar] [CrossRef] [PubMed]
  90. De Moura Menezes, R.A.; Pavanitto, D.R.; Nascimento, L.F.C. Different Response to Exposure to Air Pollutants in Girls and Boys. Rev. Paul Pediatr. 2019, 37, 166–172. [Google Scholar] [CrossRef] [PubMed]
  91. Nayebare, S.R.; Aburizaiza, O.S.; Siddique, A.; Carpenter, D.O.; Zeb, J.; Aburizaiza, A.J.; Pantea, C.; Hussain, M.M.; Khwaja, H.A. Association of Fine Particulate Air Pollution with Cardiopulmonary Morbidity in Western Coast of Saudi Arabia. Saudi Med. J. 2017, 38, 905–912. [Google Scholar] [CrossRef]
  92. Qiu, H.; Wang, L.; Zhou, L.; Pan, J. Coarse Particles (PM2.5-10) and Cause-Specific Hospitalizations in Southwestern China: Association, Attributable Risk and Economic Costs. Environ. Res. 2020, 190, 110004. [Google Scholar] [CrossRef]
  93. Shan, W.; Lu, Y.; Guo, Y.; Li, Y.; Xu, L.; Cao, L. Short-Term Association between Particular Matter Air Pollution and Pediatric Clinical Visits for Wheezing in a Subarea of Shanghai. Environ. Sci. Pollut. Res. Int. 2016, 23, 19201–19211. [Google Scholar] [CrossRef]
  94. Vahedian, M.; Khanjani, N.; Mirzaee, M.; Koolivand, A. Associations of Short-Term Exposure to Air Pollution with Respiratory Hospital Admissions in Arak, Iran. J. Environ. Health Sci. Eng. 2017, 15, 17. [Google Scholar] [CrossRef]
  95. Wang, M.; Chen, J.; Zhang, Z.; Yu, P.; Gan, W.; Tan, Z.; Bao, J. Associations between Air Pollution and Outpatient Visits for Arrhythmia in Hangzhou, China. BMC Public Health 2020, 20, 1524. [Google Scholar] [CrossRef]
  96. Wu, T.; Ma, Y.; Wu, X.; Bai, M.; Peng, Y.; Cai, W.; Wang, Y.; Zhao, J.; Zhang, Z. Association between Particulate Matter Air Pollution and Cardiovascular Disease Mortality in Lanzhou, China. Environ. Sci. Pollut. Res. Int. 2019, 26, 15262–15272. [Google Scholar] [CrossRef]
  97. Xia, X.; Zhang, A.; Liang, S.; Qi, Q.; Jiang, L.; Ye, Y. The Association between Air Pollution and Population Health Risk for Respiratory Infection: A Case Study of Shenzhen, China. Int. J. Environ. Res. Public Health 2017, 14, 950. [Google Scholar] [CrossRef]
  98. Zhang, D.; Li, Y.; Chen, Q.; Jiang, Y.; Chu, C.; Ding, Y.; Yu, Y.; Fan, Y.; Shi, J.; Luo, Y.; et al. The Relationship between Air Quality and Respiratory Pathogens among Children in Suzhou City. Ital. J. Pediatr. 2019, 45, 123. [Google Scholar] [CrossRef]
  99. Zhang, Z.; Chai, P.; Wang, J.; Ye, Z.; Shen, P.; Lu, H.; Jin, M.; Gu, M.; Li, D.; Lin, H.; et al. Association of Particulate Matter Air Pollution and Hospital Visits for Respiratory Diseases: A Time-Series Study from China. Environ. Sci. Pollut. Res. Int. 2019, 26, 12280–12287. [Google Scholar] [CrossRef]
  100. Zhu, L.; Ge, X.; Chen, Y.; Zeng, X.; Pan, W.; Zhang, X.; Ben, S.; Yuan, Q.; Xin, J.; Shao, W.; et al. Short-Term Effects of Ambient Air Pollution and Childhood Lower Respiratory Diseases. Sci. Rep. 2017, 7, 4414. [Google Scholar] [CrossRef]
  101. Bono, R.; Romanazzi, V.; Bellisario, V.; Tassinari, R.; Trucco, G.; Urbino, A.; Cassardo, C.; Siniscalco, C.; Marchetti, P.; Marcon, A. Air Pollution, Aeroallergens and Admissions to Pediatric Emergency Room for Respiratory Reasons in Turin, Northwestern Italy. BMC Public Health 2016, 16, 722. [Google Scholar] [CrossRef]
  102. Cai, J.; Yu, S.; Pei, Y.; Peng, C.; Liao, Y.; Liu, N.; Ji, J.; Cheng, J. Association between Airborne Fine Particulate Matter and Residents’ Cardiovascular Diseases, Ischemic Heart Disease and Cerebral Vascular Disease Mortality in Areas with Lighter Air Pollution in China. Int. J. Environ. Res. Public Health 2018, 15, 1918. [Google Scholar] [CrossRef]
  103. Chang, Q.; Zhang, H.; Zhao, Y. Ambient Air Pollution and Daily Hospital Admissions for Respiratory System–Related Diseases in a Heavy Polluted City in Northeast China. Environ. Sci. Pollut. Res. 2020, 27, 10055–10064. [Google Scholar] [CrossRef]
  104. Ferreira, T.; Forti, M.; de Freitas, C.; Nascimento, F.; Junger, W.; Gouveia, N. Effects of Particulate Matter and Its Chemical Constituents on Elderly Hospital Admissions Due to Circulatory and Respiratory Diseases. Int. J. Environ. Res. Public Health 2016, 13, 947. [Google Scholar] [CrossRef]
  105. Jiang, Y.; Chen, J.; Wu, C.; Lin, X.; Zhou, Q.; Ji, S.; Yang, S.; Zhang, X.; Liu, B. Temporal Cross-Correlations between Air Pollutants and Outpatient Visits for Respiratory and Circulatory System Diseases in Fuzhou, China. BMC Public Health 2020, 20, 1131. [Google Scholar] [CrossRef]
  106. Liu, L.; Liu, C.; Chen, R.; Zhou, Y.; Meng, X.; Hong, J.; Cao, L.; Lu, Y.; Dong, X.; Xia, M.; et al. Associations of Short-Term Exposure to Air Pollution and Emergency Department Visits for Pediatric Asthma in Shanghai, China. Chemosphere 2021, 263, 127856. [Google Scholar] [CrossRef]
  107. Luong, L.T.M.; Dang, T.N.; Thanh Huong, N.T.; Phung, D.; Tran, L.K.; Van Dung, D.; Thai, P.K. Particulate Air Pollution in Ho Chi Minh City and Risk of Hospital Admission for Acute Lower Respiratory Infection (ALRI) among Young Children. Environ. Pollut. 2020, 257, 113424. [Google Scholar] [CrossRef] [PubMed]
  108. Ma, Y.; Yue, L.; Liu, J.; He, X.; Li, L.; Niu, J.; Luo, B. Association of Air Pollution with Outpatient Visits for Respiratory Diseases of Children in an Ex-Heavily Polluted Northwestern City, China. BMC Public Health 2020, 20, 816. [Google Scholar] [CrossRef] [PubMed]
  109. Nayebare, S.R.; Aburizaiza, O.S.; Siddique, A.; Carpenter, D.O.; Arden Pope, C.; Mirza, H.M.; Zeb, J.; Aburiziza, A.J.; Khwaja, H.A. Fine Particles Exposure and Cardiopulmonary Morbidity in Jeddah: A Time-Series Analysis. Sci. Total Environ. 2019, 647, 1314–1322. [Google Scholar] [CrossRef] [PubMed]
  110. Ribeiro, P.C.; Nascimento, L.F.C.; Almeida, A.A.; dos Santos Targa, M.; Cesar, A.C.G. Fine Particulate Matter and Ischemic Heart Diseases Inrelation to Sex. An Ecological Time Series Study. Sao Paulo Med. J. 2019, 137, 60–65. [Google Scholar] [CrossRef]
  111. Song, J.; Lu, M.; Zheng, L.; Liu, Y.; Xu, P.; Li, Y.; Xu, D.; Wu, W. Acute Effects of Ambient Air Pollution on Outpatient Children with Respiratory Diseases in Shijiazhuang, China. BMC Pulm. Med. 2018, 18, 150. [Google Scholar] [CrossRef]
  112. Tian, Y.; Liu, H.; Wu, Y.; Si, Y.; Li, M.; Wu, Y.; Wang, X.; Wang, M.; Chen, L.; Wei, C.; et al. Ambient Particulate Matter Pollution and Adult Hospital Admissions for Pneumonia in Urban China: A National Time Series Analysis for 2014 through 2017. PLoS Med. 2019, 16, e1003010. [Google Scholar] [CrossRef]
  113. Wang, X.; Xu, Z.; Su, H.; Ho, H.C.; Song, Y.; Zheng, H.; Hossain, M.Z.; Khan, M.A.; Bogale, D.; Zhang, H.; et al. Ambient Particulate Matter (PM1, PM2.5, PM10) and Childhood Pneumonia: The Smaller Particle, the Greater Short-Term Impact? Sci. Total Environ. 2021, 772, 145509. [Google Scholar] [CrossRef]
  114. Wang, Z.; Zhou, Y.; Zhang, Y.; Huang, X.; Duan, X.; Chen, D.; Ou, Y.; Tang, L.; Liu, S.; Hu, W.; et al. Association of Change in Air Quality with Hospital Admission for Acute Exacerbation of Chronic Obstructive Pulmonary Disease in Guangdong, China: A Province-Wide Ecological Study. Ecotoxicol. Environ. Saf. 2021, 208, 111590. [Google Scholar] [CrossRef]
  115. Yang, H.; Yan, C.; Li, M.; Zhao, L.; Long, Z.; Fan, Y.; Zhang, Z.; Chen, R.; Huang, Y.; Lu, C.; et al. Short Term Effects of Air Pollutants on Hospital Admissions for Respiratory Diseases among Children: A Multi-City Time-Series Study in China. Int. J. Hyg. Environ. Health 2021, 231, 113638. [Google Scholar] [CrossRef]
  116. Yu, Y.; Yao, S.; Dong, H.; Ji, M.; Chen, Z.; Li, G.; Yao, X.; Wang, S.-L.; Zhang, Z. Short-Term Effects of Ambient Air Pollutants and Myocardial Infarction in Changzhou, China. Environ. Sci. Pollut. Res. 2018, 25, 22285–22293. [Google Scholar] [CrossRef]
  117. Zhang, Y.; Wu, Z.; Gou, K.; Wang, R.; Wang, J. The Impact of Air Pollution on Outpatient Visits of Children with Asthma in Xi’an, China. Wilderness Environ. Med. 2021, 32, 47–54. [Google Scholar] [CrossRef]
  118. Zhao, Y.; Wang, S.; Lang, L.; Huang, C.; Ma, W.; Lin, H. Ambient Fine and Coarse Particulate Matter Pollution and Respiratory Morbidity in Dongguan, China. Environ. Pollut. 2017, 222, 126–131. [Google Scholar] [CrossRef]
  119. Zhou, H.; Geng, H.; Dong, C.; Bai, T. The Short-Term Harvesting Effects of Ambient Particulate Matter on Mortality in Taiyuan Elderly Residents: A Time-Series Analysis with a Generalized Additive Distributed Lag Model. Ecotoxicol. Environ. Saf. 2021, 207, 111235. [Google Scholar] [CrossRef]
  120. Zuo, B.; Liu, C.; Chen, R.; Kan, H.; Sun, J.; Zhao, J.; Wang, C.; Sun, Q.; Bai, H. Associations between Short-Term Exposure to Fine Particulate Matter and Acute Exacerbation of Asthma in Yancheng, China. Chemosphere 2019, 237, 124497. [Google Scholar] [CrossRef]
  121. Bai, L.; Su, X.; Zhao, D.; Zhang, Y.; Cheng, Q.; Zhang, H.; Wang, S.; Xie, M.; Su, H. Exposure to Traffic-Related Air Pollution and Acute Bronchitis in Children: Season and Age as Modifiers. J. Epidemiol. Community Health 2018, 72, 426–433. [Google Scholar] [CrossRef]
  122. Chen, R.; Yin, P.; Meng, X.; Liu, C.; Wang, L.; Xu, X.; Ross, J.A.; Tse, L.A.; Zhao, Z.; Kan, H.; et al. Fine Particulate Air Pollution and Daily Mortality. A Nationwide Analysis in 272 Chinese Cities. Am. J. Respir. Crit. Care Med. 2017, 196, 73–81. [Google Scholar] [CrossRef]
  123. Gong, T.; Sun, Z.; Zhang, X.; Zhang, Y.; Wang, S.; Han, L.; Zhao, D.; Ding, D.; Zheng, C. Associations of Black Carbon and PM2.5 with Daily Cardiovascular Mortality in Beijing, China. Atmos. Environ. 2019, 214, 116876. [Google Scholar] [CrossRef]
  124. Guo, P.; Wang, Y.; Feng, W.; Wu, J.; Fu, C.; Deng, H.; Huang, J.; Wang, L.; Zheng, M.; Liu, H. Ambient Air Pollution and Risk for Ischemic Stroke: A Short-Term Exposure Assessment in South China. Int. J. Environ. Res. Public Health 2017, 14, 1091. [Google Scholar] [CrossRef]
  125. Guo, P.; Feng, W.; Zheng, M.; Lv, J.; Wang, L.; Liu, J.; Zhang, Y.; Luo, G.; Zhang, Y.; Deng, C.; et al. Short-Term Associations of Ambient Air Pollution and Cause-Specific Emergency Department Visits in Guangzhou, China. Sci. Total Environ. 2018, 613–614, 306–313. [Google Scholar] [CrossRef]
  126. Li, D.; Wang, J.; Zhang, Z.; Shen, P.; Zheng, P.; Jin, M.; Lu, H.; Lin, H.; Chen, K. Effects of Air Pollution on Hospital Visits for Pneumonia in Children: A Two-Year Analysis from China. Environ. Sci. Pollut. Res. 2018, 25, 10049–10057. [Google Scholar] [CrossRef]
  127. Li, J.; Zhang, X.; Yin, P.; Wang, L.; Zhou, M. Ambient Fine Particulate Matter Pollution and Years of Life Lost from Cardiovascular Diseases in 48 Large Chinese Cities: Association, Effect Modification, and Additional Life Gain. Sci. Total Environ. 2020, 735, 139413. [Google Scholar] [CrossRef] [PubMed]
  128. Li, M.; Tang, J.; Yang, H.; Zhao, L.; Liu, Y.; Xu, H.; Fan, Y.; Hong, J.; Long, Z.; Li, X.; et al. Short-Term Exposure to Ambient Particulate Matter and Outpatient Visits for Respiratory Diseases among Children: A Time-Series Study in Five Chinese Cities. Chemosphere 2021, 263, 128214. [Google Scholar] [CrossRef]
  129. Liang, H.; Qiu, H.; Tian, L. Short-Term Effects of Fine Particulate Matter on Acute Myocardial Infraction Mortality and Years of Life Lost: A Time Series Study in Hong Kong. Sci. Total Environ. 2018, 615, 558–563. [Google Scholar] [CrossRef] [PubMed]
  130. Lin, H.; Ratnapradipa, K.; Wang, X.; Zhang, Y.; Xu, Y.; Yao, Z.; Dong, G.; Liu, T.; Clark, J.; Dick, R.; et al. Hourly Peak Concentration Measuring the PM2.5-Mortality Association: Results from Six Cities in the Pearl River Delta Study. Atmos. Environ. 2017, 161, 27–33. [Google Scholar] [CrossRef]
  131. Liu, C.; Liu, Y.; Zhou, Y.; Feng, A.; Wang, C.; Shi, T. Short-Term Effect of Relatively Low Level Air Pollution on Outpatient Visit in Shennongjia, China. Environ. Pollut. 2019, 245, 419–426. [Google Scholar] [CrossRef] [PubMed]
  132. Liu, M.; Xue, X.; Zhou, B.; Zhang, Y.; Sun, B.; Chen, J.; Li, X. Population Susceptibility Differences and Effects of Air Pollution on Cardiovascular Mortality: Epidemiological Evidence from a Time-Series Study. Environ. Sci. Pollut. Res. 2019, 26, 15943–15952. [Google Scholar] [CrossRef] [PubMed]
  133. Luo, L.; Zhang, Y.; Jiang, J.; Luan, H.; Yu, C.; Nan, P.; Luo, B.; You, M. Short-Term Effects of Ambient Air Pollution on Hospitalization for Respiratory Disease in Taiyuan, China: A Time-Series Analysis. Int. J. Environ. Res. Public Health 2018, 15, 2160. [Google Scholar] [CrossRef] [PubMed]
  134. Qiu, H.; Yu, H.; Wang, L.; Zhu, X.; Chen, M.; Zhou, L.; Deng, R.; Zhang, Y.; Pu, X.; Pan, J. The Burden of Overall and Cause-Specific Respiratory Morbidity Due to Ambient Air Pollution in Sichuan Basin, China: A Multi-City Time-Series Analysis. Environ. Res. 2018, 167, 428–436. [Google Scholar] [CrossRef]
  135. Qu, F.; Liu, F.; Zhang, H.; Chao, L.; Guan, J.; Li, R.; Yu, F.; Yan, X. Comparison of Air Pollutant-Related Hospitalization Burden from AECOPD in Shijiazhuang, China, between Heating and Non-Heating Season. Environ. Sci. Pollut. Res. 2019, 26, 31225–31233. [Google Scholar] [CrossRef]
  136. Rodríguez-Villamizar, L.A.; Rojas-Roa, N.Y.; Fernández-Niño, J.A. Short-Term Joint Effects of Ambient Air Pollutants on Emergency Department Visits for Respiratory and Circulatory Diseases in Colombia, 2011–2014. Environ. Pollut. 2019, 248, 380–387. [Google Scholar] [CrossRef]
  137. Sui, X.; Zhang, J.; Zhang, Q.; Sun, S.; Lei, R.; Zhang, C.; Cheng, H.; Ding, L.; Ding, R.; Xiao, C.; et al. The Short-Term Effect of PM2.5/O3 on Daily Mortality from 2013 to 2018 in Hefei, China. Environ. Geochem. Health 2021, 43, 153–169. [Google Scholar] [CrossRef]
  138. Tian, Y.; Liu, H.; Wu, Y.; Si, Y.; Song, J.; Cao, Y.; Li, M.; Wu, Y.; Wang, X.; Chen, L.; et al. Association between Ambient Fine Particulate Pollution and Hospital Admissions for Cause Specific Cardiovascular Disease: Time Series Study in 184 Major Chinese Cities. BMJ 2019, l6572. [Google Scholar] [CrossRef]
  139. Wang, Y.; Zu, Y.; Huang, L.; Zhang, H.; Wang, C.; Hu, J. Associations between Daily Outpatient Visits for Respiratory Diseases and Ambient Fine Particulate Matter and Ozone Levels in Shanghai, China. Environ. Pollut. 2018, 240, 754–763. [Google Scholar] [CrossRef]
  140. Wang, Z.; Zhou, Y.; Zhang, Y.; Huang, X.; Duan, X.; Ou, Y.; Liu, S.; Hu, W.; Liao, C.; Zheng, Y.; et al. Association of Hospital Admission for Bronchiectasis with Air Pollution: A Province-Wide Time-Series Study in Southern China. Int. J. Hyg. Environ. Health 2021, 231, 113654. [Google Scholar] [CrossRef]
  141. Yao, C.; Wang, Y.; Williams, C.; Xu, C.; Kartsonaki, C.; Lin, Y.; Zhang, P.; Yin, P.; Lam, K.B.H. The Association between High Particulate Matter Pollution and Daily Cause-Specific Hospital Admissions: A Time-Series Study in Yichang, China. Environ. Sci. Pollut. Res. 2020, 27, 5240–5250. [Google Scholar] [CrossRef]
  142. Yoo, S.-E.; Park, J.-S.; Lee, S.H.; Park, C.-H.; Lee, C.-W.; Lee, S.-B.; Yu, S.D.; Kim, S.-Y.; Kim, H. Comparison of Short-Term Associations between PM2.5 Components and Mortality across Six Major Cities in South Korea. Int. J. Environ. Res. Public Health 2019, 16, 2872. [Google Scholar] [CrossRef]
  143. Zheng, P.; Wang, J.; Zhang, Z.; Shen, P.; Chai, P.; Li, D.; Jin, M.; Tang, M.-L.; Lu, H.; Lin, H.; et al. Air Pollution and Hospital Visits for Acute Upper and Lower Respiratory Infections among Children in Ningbo, China: A Time-Series Analysis. Environ. Sci. Pollut. Res. 2017, 24, 18860–18869. [Google Scholar] [CrossRef]
  144. Amsalu, E.; Wang, T.; Li, H.; Liu, Y.; Wang, A.; Liu, X.; Tao, L.; Luo, Y.; Zhang, F.; Yang, X.; et al. Acute Effects of Fine Particulate Matter (PM2.5) on Hospital Admissions for Cardiovascular Disease in Beijing, China: A Time-Series Study. Environ. Health 2019, 18, 70. [Google Scholar] [CrossRef]
  145. Atkinson, R.W.; Samoli, E.; Analitis, A.; Fuller, G.W.; Green, D.C.; Anderson, H.R.; Purdie, E.; Dunster, C.; Aitlhadj, L.; Kelly, F.J.; et al. Short-Term Associations between Particle Oxidative Potential and Daily Mortality and Hospital Admissions in London. Int. J. Hyg. Environ. Health 2016, 219, 566–572. [Google Scholar] [CrossRef]
  146. Cai, J.; Peng, C.; Yu, S.; Pei, Y.; Liu, N.; Wu, Y.; Fu, Y.; Cheng, J. Association between PM2.5 Exposure and All-Cause, Non-Accidental, Accidental, Different Respiratory Diseases, Sex and Age Mortality in Shenzhen, China. Int. J. Environ. Res. Public Health 2019, 16, 401. [Google Scholar] [CrossRef]
  147. César, A.C.G.; Nascimento, L.F. Coarse Particles and Hospital Admissions Due to Respiratory Diseases in Children. An Ecological Time Series Study. Sao Paulo Med. J. 2018, 136, 245–250. [Google Scholar] [CrossRef] [PubMed]
  148. Chen, C.; Zhu, P.; Lan, L.; Zhou, L.; Liu, R.; Sun, Q.; Ban, J.; Wang, W.; Xu, D.; Li, T. Short-Term Exposures to PM2.5 and Cause-Specific Mortality of Cardiovascular Health in China. Environ. Res. 2018, 161, 188–194. [Google Scholar] [CrossRef] [PubMed]
  149. Chen, R.; Yin, P.; Meng, X.; Wang, L.; Liu, C.; Niu, Y.; Liu, Y.; Liu, J.; Qi, J.; You, J.; et al. Associations between Coarse Particulate Matter Air Pollution and Cause-Specific Mortality: A Nationwide Analysis in 272 Chinese Cities. Environ. Health Perspect. 2019, 127, 017008. [Google Scholar] [CrossRef]
  150. Cheng, H.; Zhu, F.; Lei, R.; Shen, C.; Liu, J.; Yang, M.; Ding, R.; Cao, J. Associations of Ambient PM2.5 and O3 with Cardiovascular Mortality: A Time-Series Study in Hefei, China. Int. J. Biometeorol. 2019, 63, 1437–1447. [Google Scholar] [CrossRef]
  151. Davila Cordova, J.E.; Tapia Aguirre, V.; Vasquez Apestegui, V.; Ordoñez Ibarguen, L.; Vu, B.N.; Steenland, K.; Gonzales, G.F. Association of PM2.5 Concentration with Health Center Outpatient Visits for Respiratory Diseases of Children under 5 Years Old in Lima, Peru. Environ. Health 2020, 19, 7. [Google Scholar] [CrossRef] [PubMed]
  152. Gao, N.; Li, C.; Ji, J.; Yang, Y.; Wang, S.; Tian, X.; Xu, K.-F. Short-Term Effects of Ambient Air Pollution on Chronic Obstructive Pulmonary Disease Admissions in Beijing, China (2013–2017). Int. J. Chron Obs. Pulmon. Dis. 2019, 14, 297–309. [Google Scholar] [CrossRef]
  153. Gu, J.; Shi, Y.; Zhu, Y.; Chen, N.; Wang, H.; Zhang, Z.; Chen, T. Ambient Air Pollution and Cause-Specific Risk of Hospital Admission in China: A Nationwide Time-Series Study. PLoS Med. 2020, 17, e1003188. [Google Scholar] [CrossRef]
  154. Hsu, C.-Y.; Chiang, H.-C.; Chen, M.-J.; Chuang, C.-Y.; Tsen, C.-M.; Fang, G.-C.; Tsai, Y.-I.; Chen, N.-T.; Lin, T.-Y.; Lin, S.-L.; et al. Ambient PM2.5 in the Residential Area near Industrial Complexes: Spatiotemporal Variation, Source Apportionment, and Health Impact. Sci. Total Environ. 2017, 590–591, 204–214. [Google Scholar] [CrossRef]
  155. Lanzinger, S.; Schneider, A.; Breitner, S.; Stafoggia, M.; Erzen, I.; Dostal, M.; Pastorkova, A.; Bastian, S.; Cyrys, J.; Zscheppang, A.; et al. Associations between Ultrafine and Fine Particles and Mortality in Five Central European Cities—Results from the UFIREG Study. Environ. Int. 2016, 88, 44–52. [Google Scholar] [CrossRef]
  156. Lin, H.; Tao, J.; Du, Y.; Liu, T.; Qian, Z.; Tian, L.; Di, Q.; Rutherford, S.; Guo, L.; Zeng, W.; et al. Particle Size and Chemical Constituents of Ambient Particulate Pollution Associated with Cardiovascular Mortality in Guangzhou, China. Environ. Pollut. 2016, 208, 758–766. [Google Scholar] [CrossRef]
  157. Liu, G.; Sun, B.; Yu, L.; Chen, J.; Han, B.; Liu, B.; Chen, J. Short-Term Exposure to Ambient Air Pollution and Daily Atherosclerotic Heart Disease Mortality in a Cool Climate. Environ. Sci. Pollut. Res. 2019, 26, 23603–23614. [Google Scholar] [CrossRef]
  158. Mokoena, K.K.; Ethan, C.J.; Yu, Y.; Shale, K.; Liu, F. Ambient Air Pollution and Respiratory Mortality in Xi’an, China: A Time-Series Analysis. Respir. Res. 2019, 20, 139. [Google Scholar] [CrossRef]
  159. Patto, N.V.; Nascimento, L.F.C.; Mantovani, K.C.C.; Vieira, L.C.P.F.S.; Moreira, D.S. Exposure to Fine Particulate Matter and Hospital Admissions Due to Pneumonia: Effects on the Number of Hospital Admissions and Its Costs. Rev. Assoc. Med. Bras. (1992) 2016, 62, 342–346. [Google Scholar] [CrossRef]
  160. Pothirat, C.; Chaiwong, W.; Liwsrisakun, C.; Bumroongkit, C.; Deesomchok, A.; Theerakittikul, T.; Limsukon, A.; Tajarernmuang, P.; Phetsuk, N. Acute Effects of Air Pollutants on Daily Mortality and Hospitalizations Due to Cardiovascular and Respiratory Diseases. J. Thorac. Dis. 2019, 11, 3070–3083. [Google Scholar] [CrossRef]
  161. Pothirat, C.; Chaiwong, W.; Liwsrisakun, C.; Bumroongkit, C.; Deesomchok, A.; Theerakittikul, T.; Limsukon, A.; Tajarernmuang, P.; Phetsuk, N. The Short-Term Associations of Particular Matters on Non-Accidental Mortality and Causes of Death in Chiang Mai, Thailand: A Time Series Analysis Study between 2016–2018. Int. J. Environ. Health Res. 2021, 31, 538–547. [Google Scholar] [CrossRef]
  162. Pu, X.; Wang, L.; Chen, L.; Pan, J.; Tang, L.; Wen, J.; Qiu, H. Differential Effects of Size-Specific Particulate Matter on Lower Respiratory Infections in Children: A Multi-City Time-Series Analysis in Sichuan, China. Environ. Res. 2021, 193, 110581. [Google Scholar] [CrossRef]
  163. Qu, Y.; Pan, Y.; Niu, H.; He, Y.; Li, M.; Li, L.; Liu, J.; Li, B. Short-Term Effects of Fine Particulate Matter on Non-Accidental and Circulatory Diseases Mortality: A Time Series Study among the Elder in Changchun. PLoS ONE 2018, 13, e0209793. [Google Scholar] [CrossRef]
  164. Sun, Q.; Liu, C.; Chen, R.; Wang, C.; Li, J.; Sun, J.; Kan, H.; Cao, J.; Bai, H. Association of Fine Particulate Matter on Acute Exacerbation of Chronic Obstructive Pulmonary Disease in Yancheng, China. Sci. Total Environ. 2019, 650, 1665–1670. [Google Scholar] [CrossRef]
  165. Teng, B.; Zhang, X.; Yi, C.; Zhang, Y.; Ye, S.; Wang, Y.; Tong, D.; Lu, B. The Association between Ambient Air Pollution and Allergic Rhinitis: Further Epidemiological Evidence from Changchun, Northeastern China. Int. J. Environ. Res. Public Health 2017, 14, 226. [Google Scholar] [CrossRef]
  166. Wang, C.; Feng, L.; Chen, K. The Impact of Ambient Particulate Matter on Hospital Outpatient Visits for Respiratory and Circulatory System Disease in an Urban Chinese Population. Sci. Total Environ. 2019, 666, 672–679. [Google Scholar] [CrossRef]
  167. Yu, Y.; Yao, S.; Dong, H.; Wang, L.; Wang, C.; Ji, X.; Ji, M.; Yao, X.; Zhang, Z. Association between Short-Term Exposure to Particulate Matter Air Pollution and Cause-Specific Mortality in Changzhou, China. Environ. Res. 2019, 170, 7–15. [Google Scholar] [CrossRef]
  168. Zhu, J.; Zhang, X.; Zhang, X.; Dong, M.; Wu, J.; Dong, Y.; Chen, R.; Ding, X.; Huang, C.; Zhang, Q.; et al. The Burden of Ambient Air Pollution on Years of Life Lost in Wuxi, China, 2012–2015: A Time-Series Study Using a Distributed Lag Non-Linear Model. Environ. Pollut. 2017, 224, 689–697. [Google Scholar] [CrossRef] [PubMed]
  169. Bao, H.; Dong, J.; Liu, X.; Tan, E.; Shu, J.; Li, S. Association between Ambient Particulate Matter and Hospital Outpatient Visits for Chronic Obstructive Pulmonary Disease in Lanzhou, China. Environ. Sci. Pollut. Res. 2020, 27, 22843–22854. [Google Scholar] [CrossRef] [PubMed]
  170. Chang, J.-H.; Hsu, S.-C.; Bai, K.-J.; Huang, S.-K.; Hsu, C.-W. Association of Time-Serial Changes in Ambient Particulate Matters (PMs) with Respiratory Emergency Cases in Taipei’s Wenshan District. PLoS ONE 2017, 12, e0181106. [Google Scholar] [CrossRef] [PubMed]
  171. Chen, C.; Xu, D.; He, M.Z.; Wang, Y.; Du, Z.; Du, Y.; Qian, Y.; Ji, D.; Li, T. Fine Particle Constituents and Mortality: A Time-Series Study in Beijing, China. Environ. Sci. Technol. 2018, 52, 11378–11386. [Google Scholar] [CrossRef] [PubMed]
  172. Chen, D.; Mayvaneh, F.; Baaghideh, M.; Entezari, A.; Ho, H.C.; Xiang, Q.; Jiao, A.; Zhang, F.; Hu, K.; Chen, G.; et al. Utilizing Daily Excessive Concentration Hours to Estimate Cardiovascular Mortality and Years of Life Lost Attributable to Fine Particulate Matter in Tehran, Iran. Sci. Total Environ. 2020, 703, 134909. [Google Scholar] [CrossRef] [PubMed]
  173. Fang, X.; Fang, B.; Wang, C.; Xia, T.; Bottai, M.; Fang, F.; Cao, Y. Comparison of Frequentist and Bayesian Generalized Additive Models for Assessing the Association between Daily Exposure to Fine Particles and Respiratory Mortality: A Simulation Study. Int. J. Environ. Res. Public Health 2019, 16, 746. [Google Scholar] [CrossRef]
  174. GUO, J.; MA, M.; XIAO, C.; ZHANG, C.; CHEN, J.; LIN, H.; DU, Y.; LIU, M. Association of Air Pollution and Mortality of Acute Lower Respiratory Tract Infections in Shenyang, China: A Time Series Analysis Study. Iran J. Public Health 2018, 47, 1261–1271. [Google Scholar]
  175. Huang, F.; Chen, R.; Shen, Y.; Kan, H.; Kuang, X. The Impact of the 2013 Eastern China Smog on Outpatient Visits for Coronary Heart Disease in Shanghai, China. Int. J. Environ. Res. Public Health 2016, 13, 627. [Google Scholar] [CrossRef]
  176. Hwang, S.-H.; Lee, J.Y.; Yi, S.-M.; Kim, H. Associations of Particulate Matter and Its Components with Emergency Room Visits for Cardiovascular and Respiratory Diseases. PLoS ONE 2017, 12, e0183224. [Google Scholar] [CrossRef]
  177. Jiang, J.; Niu, Y.; Liu, C.; Chen, R.; Cao, J.; Kan, H.; Cheng, Y. Short-Term Exposure to Coarse Particulate Matter and Outpatient Visits for Cardiopulmonary Disease in a Chinese City. Ecotoxicol. Environ. Saf. 2020, 199, 110686. [Google Scholar] [CrossRef]
  178. Li, Y.R.; Xiao, C.C.; Li, J.; Tang, J.; Geng, X.Y.; Cui, L.J.; Zhai, J.X. Association between Air Pollution and Upper Respiratory Tract Infection in Hospital Outpatients Aged 0–14 Years in Hefei, China: A Time Series Study. Public Health 2018, 156, 92–100. [Google Scholar] [CrossRef]
  179. Lin, H.; Tao, J.; Qian, Z.; Ruan, Z.; Xu, Y.; Hang, J.; Xu, X.; Liu, T.; Guo, Y.; Zeng, W.; et al. Shipping Pollution Emission Associated with Increased Cardiovascular Mortality: A Time Series Study in Guangzhou, China. Environ. Pollut. 2018, 241, 862–868. [Google Scholar] [CrossRef]
  180. Liu, Y.; Xie, S.; Yu, Q.; Huo, X.; Ming, X.; Wang, J.; Zhou, Y.; Peng, Z.; Zhang, H.; Cui, X.; et al. Short-Term Effects of Ambient Air Pollution on Pediatric Outpatient Visits for Respiratory Diseases in Yichang City, China. Environ. Pollut. 2017, 227, 116–124. [Google Scholar] [CrossRef]
  181. Liu, Y.; Cui, L.; Hou, L.; Yu, C.; Tao, N.; Liu, J.; Li, Y.; Zhou, C.; Yang, G.; Li, H. Ambient Air Pollution Exposures and Newly Diagnosed Pulmonary Tuberculosis in Jinan, China: A Time Series Study. Sci. Rep. 2018, 8, 17411. [Google Scholar] [CrossRef]
  182. Mokoena, K.K.; Ethan, C.J.; Yu, Y.; Shale, K.; Fan, Y.; Liu, F.; Rong, J. The Effect of Ambient Air Pollution on Circulatory Mortality: A Short-Term Exposure Assessment in Xi’an, China. Environ. Sci. Pollut. Res. 2019, 26, 22512–22521. [Google Scholar] [CrossRef]
  183. Nascimento, L.F.C.; Vieira, L.C.P.F.; Mantovani, K.C.C.; Moreira, D.S. Air Pollution and Respiratory Diseases: Ecological Time Series. Sao Paulo Med. J. 2016, 134, 315–321. [Google Scholar] [CrossRef]
  184. Rodríguez-Villamizar, L.; Rojas-Roa, N.; Blanco-Becerra, L.; Herrera-Galindo, V.; Fernández-Niño, J. Short-Term Effects of Air Pollution on Respiratory and Circulatory Morbidity in Colombia 2011–2014: A Multi-City, Time-Series Analysis. Int. J. Environ. Res. Public Health 2018, 15, 1610. [Google Scholar] [CrossRef]
  185. Sacramento, D.S.; Martins, L.C.; Arbex, M.A.; Pamplona, Y.d.A.P. Atmospheric Pollution and Hospitalization for Cardiovascular and Respiratory Diseases in the City of Manaus from 2008 to 2012. Sci. World J. 2020, 2020, 1–8. [Google Scholar] [CrossRef]
  186. Tian, Q.; Li, M.; Montgomery, S.; Fang, B.; Wang, C.; Xia, T.; Cao, Y. Short-Term Associations of Fine Particulate Matter and Synoptic Weather Types with Cardiovascular Mortality: An Ecological Time-Series Study in Shanghai, China. Int. J. Environ. Res. Public Health 2020, 17, 1111. [Google Scholar] [CrossRef]
  187. Vahedian, M.; Khanjani, N.; Mirzaee, M.; Koolivand, A. Ambient Air Pollution and Daily Hospital Admissions for Cardiovascular Diseases in Arak, Iran. ARYA Atheroscler 2017, 13, 117–134. [Google Scholar] [PubMed]
  188. Wang, C.; Hao, L.; Liu, C.; Chen, R.; Wang, W.; Chen, Y.; Yang, Y.; Meng, X.; Fu, Q.; Ying, Z.; et al. Associations between Fine Particulate Matter Constituents and Daily Cardiovascular Mortality in Shanghai, China. Ecotoxicol. Environ. Saf. 2020, 191, 110154. [Google Scholar] [CrossRef] [PubMed]
  189. Wang, H.; Lu, F.; Guo, M.; Fan, W.; Ji, W.; Dong, Z. Associations between PM1 Exposure and Daily Emergency Department Visits in 19 Hospitals, Beijing. Sci. Total Environ. 2021, 755, 142507. [Google Scholar] [CrossRef]
  190. Zhang, D.; Tian, Y.; Zhang, Y.; Cao, Y.; Wang, Q.; Hu, Y. Fine Particulate Air Pollution and Hospital Utilization for Upper Respiratory Tract Infections in Beijing, China. Int. J. Environ. Res. Public Health 2019, 16, 533. [Google Scholar] [CrossRef]
  191. Zhang, F.; Zhang, H.; Wu, C.; Zhang, M.; Feng, H.; Li, D.; Zhu, W. Acute Effects of Ambient Air Pollution on Clinic Visits of College Students for Upper Respiratory Tract Infection in Wuhan, China. Environ. Sci. Pollut. Res. 2021, 28, 29820–29830. [Google Scholar] [CrossRef] [PubMed]
Figure 1. Flowchart for the article extraction process of time series studies on PM2.5 and health effects.
Figure 1. Flowchart for the article extraction process of time series studies on PM2.5 and health effects.
Atmosphere 14 00856 g001
Figure 2. Distribution of time series studies of PM2.5 with cardiovascular and respiratory health effects by geographic regions.
Figure 2. Distribution of time series studies of PM2.5 with cardiovascular and respiratory health effects by geographic regions.
Atmosphere 14 00856 g002
Figure 3. Frequency of time series studies of PM2.5 with health effects by (a) income groups and (b) countries. Notes: Based on GNI per capita in USD by the World Bank Gross National Income (GNI) Economies [31]: High-income > 12,695, Upper-middle income = 4096–12,695, Lower-middle income = 1046–4095.
Figure 3. Frequency of time series studies of PM2.5 with health effects by (a) income groups and (b) countries. Notes: Based on GNI per capita in USD by the World Bank Gross National Income (GNI) Economies [31]: High-income > 12,695, Upper-middle income = 4096–12,695, Lower-middle income = 1046–4095.
Atmosphere 14 00856 g003
Figure 4. Main journals for selected articles on time series study of PM2.5 with cardiovascular and respiratory health effects from January 2016 to January 2021. Notes: ESPR = Environmental Science and Pollution Research, IJERPH = International Journal of Environmental Research and Public Health, STOTEN = Science of the Total Environment, Environ. Res. = Environmental Research, Environ. Pollut. = Environmental Pollution, EHP = Environmental Health Perspectives, Ecotoxicol. Environ. Saf. = Ecotoxicology and Environmental Safety, BMC = BioMed Central.
Figure 4. Main journals for selected articles on time series study of PM2.5 with cardiovascular and respiratory health effects from January 2016 to January 2021. Notes: ESPR = Environmental Science and Pollution Research, IJERPH = International Journal of Environmental Research and Public Health, STOTEN = Science of the Total Environment, Environ. Res. = Environmental Research, Environ. Pollut. = Environmental Pollution, EHP = Environmental Health Perspectives, Ecotoxicol. Environ. Saf. = Ecotoxicology and Environmental Safety, BMC = BioMed Central.
Atmosphere 14 00856 g004
Table 1. Methodology for time series studies of PM2.5 and health effects.
Table 1. Methodology for time series studies of PM2.5 and health effects.
CategoriesN (%)
Study duration
   Less than 7 years111 (80.4)
   7 years and more27 (19.6)
Type of time series analysis
   GAM and Poisson103 (74.6)
   GLM and Poisson24 (17.4)
   Negative Binomial2 (1.4)
   Others9 (6.5)
ICD codes
   ICD-1098 (71.0)
   ICD-911 (8.0)
   Both ICD5 (3.6)
   No classification24 (17.4)
Table 2. Time series study of PM2.5 and health effects based on age groups vulnerability.
Table 2. Time series study of PM2.5 and health effects based on age groups vulnerability.
OutcomesChildren (Only)
(n = 17)
Elderly (Only)
(n = 58)
Children & Elderly
(n = 14)
All Ages
(n = 49)
Health outcomes
   Mortality026015
   Hospital admission616613
   Clinic or ED visits1111614
   Combined0527
Disease
   Cardiovascular021115
   Respiratory1718819
   Combined019515
Table 3. Highlights of long-term time series studies (≥7 years) on PM2.5 and health effects (n = 27).
Table 3. Highlights of long-term time series studies (≥7 years) on PM2.5 and health effects (n = 27).
Author (Reference)LocationStudy PeriodHealth OutcomeDiseases (ICD Classification)Key FindingsVulnerable Groups
Eastern & South-Eastern Asia
Chai et al., 2019 [37]Lanzhou, China10 years
(2007–2016)
Hospital visitsRD (ICD-10: J00–J99)
  • PM2.5 concentrations were associated with an increase in the daily outpatient visits for RD.
  • A lag effect was observed, and this effect was the strongest on day 1. With each 10 μg/m3 increase in PM2.5, the daily outpatient visits for respiratory diseases increased by 0.53% (95% CI: 0.22–0.84%).
Each 10-μg/m3 increase in PM2.5 had a cumulative effect on RD visits
  • Age: Children aged ≤ 18 years showed maximum on day 14 (RR = 1.0213, 95% CI: 1.0128–1.0299).
  • Gender: Risk changes in males RR = 1.0053 (95% CI: 1.0022–1.0085) and females RR = 1.0053 (95% CI: 1.0020–1.0086)
Chen et al., 2021 [38]Nanjing, China16 years
(2004–2019
Hospital admissionCVD (ICD-10: I00–I99), IHD (ICD-10: I20–I25), and CBVD (ICD-10: I60–I69).Cumulative effect estimates for PM2.5 on IHD mortality were elevated and statistically significant within 27 (2.11%; 95% CI: 0.12–.27%) and 22 (2.63%; 95% CI: 0.39–4.91%) days
  • NA
Xu et al., 2019 [39]Heifei, China11 years
(2007–2016)
MortalityCVD (ICD-10: I00–I99), IHD (ICD-10: I20–I25), and CBVD (ICD-10: I60–I69)
  • CVD deaths are significantly higher with seasonal changes during winter compared to summer.
  • Greatest impact for PM2.5 was at lag 1 with ER of 0.84% (95% CI: 0.04–1.65%) and lag 0–5 with 3.14% (95% CI: 0.03–6.36%).
  • Gender: Females suffered more adverse effects of PM2.5, ER = 5.06% (95% CI 0.03–10.34%) at lag 0–5.
  • Age: PM2.5 increased risk of CVD mortality on age < 65 years ER = 15.18% (95% CI: 2.31–29.66%) at lag 0–7.
Lin et al., 2016 [40]Hong Kong14 years
(1998–2011)
MortalityRD (ICD-10: J00–J99) A positive but non-significant synergistic interaction between daily mean and variation on RD and pneumonia mortality
  • NA
Lin et al., 2017 [41]Hong Kong11 years
(2001–2011)
MortalityCVD (ICD-9: 390–459 or ICD-10: I00–I99)
RD (ICD-9: 460–519 or ICD-10: J00–J99)
PM2.5 was significantly associated with mortality; the highest increase in daily mean PM2.5 at lag03 corresponded to ER of 2.77% (95% CI: 1.50–4.05%) increase in CVD mortality and 2.07% (95% CI: 0.49–3.67%) increase in RD mortality.
  • NA
Yap et al., 2019 [42] Singapore13 years
(2001–2013)
MortalityCVD (ICD-9390–459) and (ICD-10 I00–I99)
Non-accidental deaths (ICD-9000–799) and (ICD-10: A00–R99)
An increase of 10 μg/m3 in PM2.5 was associated with significant increases in non-accidental mortality ER: 0.660%; 95% CI: 0.204–1.118%) and CVD mortality (ER: 0.883%; 95% CI: 0.121–1.621%).
  • Elderly: significant CVD mortality in elderly ≥65 years but not in those <65 years were seen in the acute phase of lag 0–5 days. However, the effects turned protective at a cumulative lag of 30 days.
Kwon et al., 2019 [43]Seoul, South Korea9 years
(2007–2015)
Hospital admissionCVD: Atrial fibrillation (AF) and a primary diagnosis of CVD (ICD-10: I00–I99),A 10-μg/m3 increase in ambient PM2.5 showed significantly increased admissions RR = 1.045; (95% CI: 1.002–1.089) at lag 3
  • Gender: Effects of PM2.5 was prominent in men (1.08; 95% CI: 1.02–1.14) at lag 3
  • Age: Non-elderly aged <65 years (RR = 1.11; 95% CI: 1.04–1.20)
Oh et al., 2020 [44]South Korea (seven metropolitan cities)8 years
(2008–2016)
Hospital admissionALRIA 10 μg/m3 increase in the 7-day moving average of PM2.5 was associated with a 1.20% (95% CI: 0.71–1.71) increase in ALRI hospitalization
  • Age: Study conducted among children aged 0–5 years
  • Gender: Association PM2.5 with ALRI admission higher in boys (1.31%, 95% CI: 0.75–1.86) compared to girls (1.02%, 95% CI: 0.45–1.58)
Qiu et al., 2020 [45]Taipei, Taiwan8 years
(2010–2017)
Hospital admissionRD (ICD-10: J00–J99), pneumonia (ICD-10: J12–J18), COPD (ICD-10: J40–J44), asthma (ICD-10: J45–J46)A strong association of PM2.5 with all-RD and asthma admissions; percentage change for RD in association with an IQR increased at different lags (Lag02 and Lag03)
  • NA
Oceania
Guo et al., 2020 [46]Hazelwood, Australia7 years
(2009–2015)
EDV and hospital admissionCVD (ICD-10: I00–I99); CBVD (ICD-10: I61–I69), IHD (I ICD-10: 20–I25)
RD (ICD-10: J00–J99); COPD (J41–J44), asthma (J45–J46).
  • For each 10 mg/m3 increase of PM2.5 in lag (0–7) days, the risk of ED visit was significantly increased by 14% for RD, 22% for COPD with asthma, and 39% for COPD alone.
  • Risk of admissions was significantly increased by 28% for COPD and asthma
  • NA
Salimi et al., 2017 [47]Sydney, Australia11 years
(2004–2015)
EADRD & CVD: breathing problems, chest pain, cardiac or respiratory arrest, and death, stroke or CBVD
  • Each increase of 10 μg/m3 in PM2.5 were positively associated with same-day EAD for breathing problems (RR = 1.03, 95% CI: 1.02–1.04), arrest (RR = 1.03, 95% CI: 1.00–1.06), chest pain (RR = 1.01 CI: 1.00–1.02)
  • NA
Europe & Northern America
Strosnider et al., 2019 [48]United States (17 states)15 years
(2000–2014)
EDVRD (ICD-9: 460–519)
  • Each 10-mg/m3 increase in PM2.5 on Lag (0–6) increased the risk for RD; RR = 1.020 (CI: 1.017–1.023).
  • Children: RRs between all RD and PM2.5 was higher among children than adults
Krall et al., 2017 [49]United States (Atlanta, Birmingham,
St. Louis, Dallas)
11 years
(1999–2009)
EDVRD: pneumonia (ICD-9: 480–486), COPD (ICD-9: 491, 492, 496), URI (ICD-9: 460–465, 466.0, 477), and asthma and/or wheeze (ICD-9: 493, 786.07)
  • The associations for PM2.5 with RD visits were frequently positive and significant across cities, but the lag of greatest association varied between cities
  • An IQR increase in lag 2 for PM2.5 associated with increased risk (RR) 1.006 (95% CI: 1.003–1.010) in Atlanta, 1.008 (95% CI: 0.996–1.019) in Birmingham, 1.007 (95% CI: 0.999–1.016) in St. Louis, 1.001 (95% CI: 0.989–1.013) in Dallas
  • NA
Ye et al., 2018 [50]Atlanta, United States16 years
(1998–2013)
EDVCVD: IHD (ICD-9: 410–414), cardiac dysrhythmias (ICD-9: 427), CHF (ICD-9: 428), or CBVD (ICD-9: 433–437, 443–445, 451–453).
  • RR for CVD was positive for PM2.5 exposure [RR 1.0112 (95% CI: 0.990–1.0214)]
  • RR for CVD was also positive for PM2.5 components (OC, EC, NO3, Si, Ca, Fe, Zn, and water-soluble Fe)
  • NA
Ebisu et al., 2019 [51]California, United States8 years
(2002–2009)
Hospital admissionCVD: (ICD-9: 390–459)
RD: (ICD-9: 460–519)
Exposure to an increase in PM2.5 vehicular emissions associated with increased risk for CVD admission and RD hospitalizations in specific groups Each IQR increase in PM2.5 emissions is associated with:
  • Age: Elderly (≥65 years) increased risk of CVD admission 1.32% (95% CI: 0.16–2.49) at lag 0
  • Children: increased risk of RD hospitalizations (0–18 years) 3.58% (95% CI: 0.90–6.33) at lag 2
Blomberg et al., 2019 [52]United States (108 cities)14 years
(1999–2013)
Mortality CVD (ICD-10: I01–I59)
RD (ICD-10: J00–J99)
  • A 10 μg/m3 increase in PM2.5 was associated with a 2.97% (95% CI: 2.16–3.79) increase in CVD mortality in the spring, as compared with a 1.26% (95% CI: 0.57–1.95) increase in the fall.
  • RD mortality was found to have higher estimates of risk compared to CVD across all seasons.
  • NA
Hsu et al., 2017 [53]New York, United States16 years
(1991–2006)
Hospital admissionCVD: CRHD (ICD-9: 393–396), hypertension (401–405), IHD (410–414), cardiac dysrhythmias (427), heart failure (428), and other CVD (430–434, 436–438)
  • PM2.5 was positively associated with CVD hospitalizations; each 10-μg/m3 increment in PM2.5 concentration accounted for a 1.37% increase in CVD (95% CI: 0.90%–1.84%)
  • PM2.5 effect was strongest in winter, with an additional 2.06% (95% CI: 1.33–2.80%) increase in CVD.
  • NA
Bi et al., 2020 [54]Los Angeles, United States12 years
(2005–2016)
EDV and hospital admissionCVD (ICD-10: I20–I79)
RD (ICD-10: J45–J46)
  • In 2013–2016, the risk of CVD in ED visits associated with a 10 g/m3 rise in 4-day PM2.5 (lag 0–3) was greater (RR = 1.020, 95% CI: 1.010–1.030) compared to 2005–2008 (RR = 1.003, 95% CI: 0.996–1.010)
  • Risk estimates for asthma were higher in 2005–2008 (RR = 1.018, 95% CI: 1.006–1.029) but decreased in the following decades
  • Specific age groups
Qiu et al., 2020 [55]New England, United States13 years
(2000–2012)
Hospital admissionCVD specific on AMI, CHF and IS
  • Each 10 μg/m3 increase in lag0–lag5 cumulative PM2.5 exposure on average increased admissions rate by 4.3% (95% CI: 2.2–6.4%) AMI, 3.9% (95% CI: 2.4–5.5%) CHF, 2.6% (95% CI: 0.4–4.7%) IS
Each 10 μg/m3 increase in PM2.5 associated with:
  • Gender: Females had a higher risk of CHF admissions than males (p = 0.040)
  • Comorbidity: Diabetic elderly had higher risks of AMI admissions compared to non-diabetic (p = 0.010)
Yitshak-Sade et al., 2018 [56]New England, United States11 years
(2001–2011)
Hospital admissionCVD (ICD 9: 390–429) or ischemic stroke (ICD 9: 432–435)
RD (ICD 9: 460–519)
  • An IQR (2.3 μg/m3) increase of PM2.5 exposure increased admissions by 4.09% (95% CI: 3.31–4.87) for RD and 6.58% (95% CI: 5.90–7.26) for CVD
  • Effect of PM2.5 exposure on CVD admissions was stronger on colder days (0.56%, 95% CI: 0.21–0.91) compared to hotter days (−0.30%, 95% CI: −0.57–−0.03; p < 0.001)
  • Elderly (≥65 years)
Pearce et al., 2018 [57]South Carolina, United States12 years
(2002–2013)
EDV and hospital admissionCVD: URI (ICD-9: 460–466, 477; CHF (ICD-9: 428); IHD (ICD-9: 410–414)
RD: Asthma (ICD-9: 493, 786.07)
  • A significant positive association between asthma with PM2.5 (lag 2, 3), with the largest RR of 1.8% (95% CI: = 1.1–2.2%).
  • PM2.5 was also significant with URI and IHD but not for CHF.
  • NA
Solimini and Renzi, 2017 [58]Rome, Italy14 years
(2001–2014)
EDV Atrial fibrillation (AF) with ICD-9: 427.31
  • For each 10 μg/m3 increase of PM2.5 at lag 0–1 day, the effect estimates for AF was 2.95%; 95% CI: 1.35–4.67%) at immediate lags, and 3.43%; 95% CI: 0.42–6.66% for extended lag
  • Age: Elderly ≥75 years showed the percent increase in the risk of AF admission per 10 μg/m3 increase of PM2.5 was 5.01% (95% CI: 2.59–7.74)
  • Gender: significant association between PM2.5, EDV for AF, and females was at immediate lag (3.51%; 95% CI: 1.29–5.90%).
Kuźma et al., 2020 [59]Bialystok, Poland10 years
(2008–2017)
Mortality CVD (ICD-10: I01–I59)
  • PM2.5 was discovered to have no effect on CVD daily mortality, except for the subgroup (males)
  • Gender: Each 10-μg/m3 increased of PM2.5 increased risk for CVD mortality in males; RR = 1.07 (95% CI: 1.02–1.12); p = 0.01
Kollanus et al., 2016 [60] Helsinki, Finland10 years
(2001–2010)
Hospital admission and mortalityCVD (ICD-10: I01–I59)
RD (ICD-10: J00–J64, J65–J99)
  • Each 10 mg/m3 increase in PM2.5 is associated with increased CVD mortality, with a percentage change of 12.4%, 95% CI: 0.2–26.5%) at lag 3
  • Age: Each 10 mg/m3 increase in PM2.5 is associated with increased CVD mortality in the elderly (≥65 years; 13.8%, 95% CI: 0.6%–30.4%) at a lag 0 and (11.8%, 95% CI: 2.2–27.7%) at lag 3
Central & Southern Asia
Borsi et al., 2020 [61]Ahvaz, Iran11 years
(2008–2018)
Hospital admissionCVD: deep venous thrombosis (DVT)
  • There was a significant relation between exposure to PM2.5 and DVT admissions; RR = 1.003 (95% CI: 1.000–1.005) at lag 0
Each 10 μg/m3 increase in PM2.5, increased risk of DVT admissions:
  • Gender: Females, RR = 1.004 (95% CI: 1.001–1.008) at lag 0 and lag 7
  • Age: ≤60 years, RR = 1.005 (95% CI: 1.002–1.009)
Latin America & Caribbean
Tapia et al., 2020 [62]Lima, Peru7 years
(2010–2016)
Hospital visitCVD (ICD-10: I20–I25, I63–I67)
RD (ICD-10: J0–J45, J00–J06, J09–J22, J30–J45)
  • ER visits for RD increased by 4% (95% CI: 0–5%) for each IQR increment in PM2.5. Visits for ischemic heart disease (adults, 18–64 years) were 11% (1, 24%), while visits for stroke were 10% (3–18%).
  • Poverty: Districts with higher poverty showed significant associations between PM2.5 and RD visits
Multiple Countries
Liu et al., 2019 [31]Multi countries (652 cities, 24 countries)30 years
(1986–2015)
Mortality CVD (I00–I99), and RD (J00–J99)
  • Average daily all-cause mortality increased by 0.44% (95% CI: 0.39–0.50), daily CVD mortality increased by 0.36% (95% CI: 0.30–0.43), and daily RD mortality increased by 0.47% (95% CI: 0.35–0.58) for every 10 g/m3 increase in the 2-day moving average of PM10 concentration
  • NA
Notes: PM2.5 = particulate matter with aerodynamic diameter ≤2.5 μm, CVD = cardiovascular disease, RD = respiratory diseases, COPD = chronic obstructive pulmonary disease, AMI = Acute myocardial infarction, CHF = congestive heart failure, IHD = ischemic heart disease, IS = ischemic stroke, CRHD = chronic rheumatic heart disease CBVD = cerebrovascular disease, ALRI = acute lower respiratory infection, URI = upper respiratory infections, IS = ischemic stroke (IS), DVT = deep venous thrombosis, ICD= International Classification of Diseases, ED = emergency department, EAD = Emergency ambulance dispatches, EDV = Emergency department visits, ER = excess risk, RR = Relative risk, CI = Confidence Interval, IQR = interquartile range, NA = non-applicable.
Table 4. Highest Relative Risks (RRs) by cardiovascular and respiratory diseases.
Table 4. Highest Relative Risks (RRs) by cardiovascular and respiratory diseases.
Diseases Outcomes Short-Term (Less than 7 Years)Long-Term (7 Years & above)
Mean
(SD)
Q1Q2 (Median)Q3MinMaxMean
(SD)
Q1Q2 (Median)Q3MinMax
Cardiovascular1.0378 (0.066)1.00731.02391.04850.82001.28801.0503
(0.0603)
1.01491.02971.05821.00501.2700
Respiratory1.0493 (0.0751)1.00821.01691.07230.91321.38001.0391
(0.0382)
1.01391.03551.04071.00741.1580
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Wan Mahiyuddin, W.R.; Ismail, R.; Mohammad Sham, N.; Ahmad, N.I.; Nik Hassan, N.M.N. Cardiovascular and Respiratory Health Effects of Fine Particulate Matters (PM2.5): A Review on Time Series Studies. Atmosphere 2023, 14, 856. https://doi.org/10.3390/atmos14050856

AMA Style

Wan Mahiyuddin WR, Ismail R, Mohammad Sham N, Ahmad NI, Nik Hassan NMN. Cardiovascular and Respiratory Health Effects of Fine Particulate Matters (PM2.5): A Review on Time Series Studies. Atmosphere. 2023; 14(5):856. https://doi.org/10.3390/atmos14050856

Chicago/Turabian Style

Wan Mahiyuddin, Wan Rozita, Rohaida Ismail, Noraishah Mohammad Sham, Nurul Izzah Ahmad, and Nik Muhammad Nizam Nik Hassan. 2023. "Cardiovascular and Respiratory Health Effects of Fine Particulate Matters (PM2.5): A Review on Time Series Studies" Atmosphere 14, no. 5: 856. https://doi.org/10.3390/atmos14050856

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop